NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Consolidation
The consolidated financial statements include the accounts of JBT Marel Corporation (JBT Marel, we, or the Company) and all wholly-owned subsidiaries. All intercompany investments, accounts, and transactions have been eliminated. On January 2, 2025, the Company changed its name from John Bean Technologies Corporation to JBT Marel Corporation.
Revision of Previously Issued Financial Statements
In the third quarter of 2025, the Company identified and corrected certain errors relating to the presentation of its Statements of Cash Flows specific to financing activities. The Company improperly reported revolving credit facility cash activity on a net basis, resulting in an understatement of gross repayments and borrowings for the revolving credit facility for the year ended December 31, 2023, as detailed below.
| | | | | | | | | | | | | | | | | |
| (In millions) | Year Ended December 31, 2023 |
| Consolidated Statement of Cash Flows | As Reported | | Adjustment | | As Revised |
| Repayment of domestic credit facility | $ | — | | | (1,026.7) | | | $ | (1,026.7) | |
| Proceeds from domestic credit facility, net of debt issuance costs | $ | — | | | 687.1 | | | $ | 687.1 | |
| Net proceeds (payments) from domestic credit facilities, net of debt issuance cost | $ | (339.6) | | | 339.6 | | | $ | — | |
| Cash (required) provided by continuing financing activities | $ | (354.1) | | | — | | | $ | (354.1) | |
The cash flows presented for the year ended December 31, 2024 were properly stated. Management determined this error did not have any impact on the total net cash provided (required) by continuing financing activities line on the Statement of Cash Flows for any of the revised periods, and were not material to the Company’s financial statements for the periods impacted.
Strategic Acquisition of Marel hf.
On January 2, 2025, the Company completed the acquisition of Marel. Refer to Note 2. Acquisitions for additional information on the acquisition of Marel.
Business Segments
Following the acquisition of Marel on January 2, 2025, the Company determined that it had two reportable segments: the legacy pre-acquisition operations of JBT and the legacy pre-acquisition operations of Marel, which were comprised of the legacy operations of each business. During the fourth quarter of 2025, the Company realigned its reportable segments to better reflect the continued integration of its operating model. The Company operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. Refer to Note 20. Business Segments for additional information.
Discontinued Operations
On August 1, 2023, the Company completed the sale of its former AeroTech business segment (“AeroTech”) to Oshkosh Corporation, a Wisconsin corporation (the “Purchaser”). All prior period financial results from the operations of AeroTech have been presented as discontinued operations. Amounts pertaining to results of operations, financial condition and cash flows throughout the document are from the Company’s continuing operations unless otherwise noted. Refer to Note 3, Discontinued Operations for further information.
Use of estimates
Preparation of financial statements that follow U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Cash and cash equivalents
Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less.
Restricted Cash
Restricted cash is recorded at fair value (Level 1 fair value measurement) and consists of money market securities, intended to fund one of the Company's employee deferred compensation plans.
Marketable Securities
The Company may invest portions of its excess cash in different marketable securities. Marketable securities with original maturities of three months or more are classified as held-to-maturity debt securities. Interest income is recorded as it is earned within Interest income in the Consolidated Statements of Income.
Allowance for credit losses
The measurement of expected credit losses under the Current Expected Credit Loss (“CECL”) methodology is applicable to financial assets measured at amortized cost, which includes trade receivables, contract assets, and non-current receivables. An allowance for credit losses under the CECL methodology is determined using the loss rate approach and measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The CECL allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. The allowance for credit losses as of December 31, 2025 and 2024 was $13.6 million and $5.2 million, respectively.
Inventories
Inventories are stated at the lower of cost or net realizable value, with the Company regularly evaluating demand to record provisions that write down excess and obsolete inventory to its net realizable value. Inventory costs include those costs directly attributable to products, including all manufacturing overhead but excluding costs to distribute. Cost is determined on the first-in, first-out (“FIFO”) basis.
Property, plant, and equipment
Property, plant, and equipment are recorded at cost. Depreciation for financial reporting purposes is provided principally on the straight-line basis over the estimated useful lives of the assets (land improvements—20 to 35 years; buildings—20 to 50 years; and machinery and equipment—3 to 20 years). Gains and losses are reflected in the Selling, general and administrative expense on the Consolidated Statements of Income upon the sale or retirement of assets. Expenditures that extend the useful lives of property, plant, and equipment are capitalized and depreciated over the estimated new remaining life of the asset. Leasehold improvements are recorded at cost and depreciated over the standard life of the type of asset or the remaining life of the lease, whichever is shorter.
Capitalized software costs
We capitalize costs incurred to purchase software or internal and external costs incurred during the application development stage of software projects. These costs are amortized on a straight-line basis over the estimated useful lives of the assets and are reflected in Selling, general and administrative expense on the Consolidated Statements of Income. For capitalized software, the useful lives range from three to ten years.
We capitalize costs incurred with the implementation of cloud computing arrangements that are service contracts, consistent with our policy for software developed or obtained for internal use.
Goodwill
The Company tests goodwill for impairment annually during the fourth quarter and whenever events occur or changes in circumstances indicate that impairment may have occurred. Impairment testing is performed for each of the Company's reporting units by first assessing qualitative factors to see if further testing of goodwill is required. Qualitative factors may include, but are not limited to economic conditions, industry and market considerations, cost factors, overall financial performance of the reporting units and other entity and reporting unit specific events. If the Company concludes that it is more likely than not that a reporting unit’s fair value is less than its carrying amount based on the qualitative assessment, then a quantitative test is required. The Company may also choose to bypass the qualitative assessment and perform the quantitative test. In performing the quantitative test, the Company determines the fair value of a reporting unit using the “income approach” valuation method. The Company uses a discounted cash flow model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate cost of capital rate. Judgment is required in developing the assumptions for the discounted cash flow model. These assumptions include revenue growth rates, adjusted EBITDA margin, discount rates, perpetuity growth rates, future capital expenditures, and working capital requirements, among others. If the fair value of a reporting unit exceeds its carrying value, the Company considers that goodwill not impaired. If the carrying amount of a reporting unit exceeds its fair value, we recognize an impairment loss in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
Refer to Note 7. Goodwill and Intangible Assets for further details of the Company’s annual and interim goodwill impairment assessments performed in the fourth quarter of 2025.
Acquired intangible assets
Intangible assets with finite useful lives are subject to amortization on a straight-line basis over the expected period of economic benefit, which range from less than 4 years to 26 years. The Company evaluates whether events or circumstances have occurred that warrant a revision to the remaining useful lives of intangible assets. In cases where a revision is deemed appropriate, the remaining carrying amounts of the intangible assets are amortized over the revised remaining useful life.
The carrying values of intangible assets with indefinite lives are reviewed for recoverability on an annual basis, and whenever events occur or changes in circumstances indicate that impairment may have occurred. The facts and circumstances considered include an assessment of the recoverability of the cost of intangible assets from future cash flows to be derived from the use of the asset. It is not possible to predict the likelihood of any possible future impairments or, if such an impairment were to occur, the magnitude of any impairment. However, any potential impairment would be limited to the carrying value of the indefinite-lived intangible asset.
For intangible assets with indefinite lives, the Company also evaluates whether events or circumstances have occurred that warrant a revision of their useful lives from an indefinite life to finite useful life. In cases where a revision is deemed appropriate, the carrying amounts of such intangible assets are amortized over the revised finite useful life.
The Company completed its annual evaluation for impairment of all indefinite-lived intangible assets as of October 31, 2025, which did not result in any impairment. Similar conclusions were reached as of October 31, 2024 and 2023.
Long-lived assets
Long-lived assets other than goodwill and acquired indefinite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the long-lived asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that an impairment loss has occurred, the loss is measured as the amount by which the carrying amount of the long-lived asset exceeds its fair value.
We have evaluated the current environment as of December 31, 2025 and the year then ended and have concluded there is no event or circumstance that has caused an impairment of our long-lived assets. We will continue to monitor the environment to determine whether the impacts to the Company represent an event or change in circumstances that may trigger a need to assess for useful life revision or impairment.
Revenue recognition
Revenue is measured based on consideration specified in a contract with a customer, and excludes any sales incentives. The Company recognizes revenue when or as it satisfies a performance obligation by transferring control of a product or service to a customer.
Performance Obligations & Contract Estimates
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation based on its respective stand-alone selling price and recognized as revenue when, or as, the performance obligation is satisfied.
The Company’s contracts with customers often include multiple promised goods and/or services. For instance, a contract may include equipment, installation, optional warranties, periodic service calls, etc. The Company frequently has contracts for which the equipment and installation are considered a single performance obligation. In these instances the installation services are not separately identifiable as the installation goes above and beyond the basic assembly, set-up and testing and therefore significantly customizes or modifies the equipment. However, the Company also has contracts where the installation services are deemed to be separately identifiable as the nature of these services are considered basic assembly, set-up and testing, and are therefore deemed to be a separate performance obligation. This generally occurs in contracts where the Company manufactures standard equipment.
When a performance obligation is separately identifiable, as defined in ASC 606, Revenue from Contracts with Customers, the Company allocates a portion of the contract price to the obligation and recognizes it separately from the other performance obligations. Contract price allocation among multiple performance obligations is based on the relative standalone selling price of each distinct good or service in the contract. When not sold separately, an estimate of the standalone selling price is determined using expected cost plus a reasonable margin.
The timing of revenue recognition for each performance obligation is either over time as control transfers or at a point in time. The Company recognizes revenue over time for contracts that provide service over a period of time, for refurbishments of customer-owned equipment, and for highly customized equipment for which the Company has an enforceable right to collect payment upon customer cancellation for performance completed to date. Revenue generated from standard equipment, highly customized equipment contracts without an enforceable right to payment for performance completed to date, as well as aftermarket parts and a portion of aftermarket services sales, are recognized at a point in time.
The Company utilizes the “cost-to-cost” input method to recognize product revenue over time. The Company measures progress based on costs incurred to date relative to total estimated cost at completion. Incurred cost represents work performed, which corresponds with, and therefore depicts, the transfer of control to the customer. Contract costs include labor, material, and certain allocated overhead expense. Material costs are considered incurred, and therefore included in the cost-to-cost measure of progress, when they are used in manufacturing and therefore customize the asset. Cost estimates are based on assumptions and estimates to project the outcome of future events; including the estimated labor and material costs required to complete open projects. During the year, we recognized $1,644.6 million in revenue for over time projects using the cost-to-cost method.
Revenue attributable to equipment which qualifies as point in time is recognized when customers take control of the asset. For equipment where installation is separately identifiable, the Company generally determines that control transfers when the customer has obtained legal title and the risks and rewards of ownership, which is dependent upon the shipping terms within the contract. For customized equipment where installation is not separately identifiable, but where the Company does not have an enforceable right to payment for performance completed to-date, it defines control transfer as the point in time in which it is able to objectively verify that the customer has the capability of full use of the asset as intended per the contract. Service revenue is recognized over time either proportionately over the period of the underlying contract or when services are complete, depending on the terms of the arrangement.
Any expected losses for a contract are charged to earnings, in total, in the period such losses are identified.
The Company generally bills customers in advance, and progress billings generally are issued upon the completion of certain phases of the work as stipulated in the contract. The Company may extend credit to customers in line with industry standards where it is strategically advantageous.
Research and development
The objectives of the research and development programs are to create new products and business opportunities in relevant fields, and to improve existing products. Research and development costs are expensed as incurred. Research and development expense of $116.3 million, $20.9 million, and $20.5 million for 2025, 2024, and 2023, respectively, is recorded in Selling, general and administrative expense.
Income taxes
The Company’s provision for income taxes includes amounts payable or refundable for the current year, the effects of deferred taxes and impacts from uncertain tax positions, if applicable. We establish deferred tax liabilities or assets for temporary differences between financial and tax reporting basis and subsequently adjust them to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We record a valuation allowance reducing deferred tax assets when it is more likely than not that such assets will not be realized. Valuation allowances are evaluated periodically and may be subject to change in future reporting periods.
We recognize tax benefits in our financial statements from uncertain tax positions only if it is more likely than not that the tax position will be sustained based on the technical merits of the position. The amount we recognize is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon resolution. Future changes related to the expected resolution of uncertain tax positions could affect tax expense in the period when the change occurs. Interest and penalties related to underpayment of income taxes are classified as income tax expense.
We monitor for changes in tax laws and reflect the impacts of tax law changes in the period of enactment. When there is refinement to tax law changes in subsequent periods, we account for the new guidance in the period when it becomes known.
Stock-based employee compensation
The Company measures compensation cost on restricted stock awards based on the market price of common stock at the grant date and the number of shares awarded. The compensation cost for each award is recognized ratably over the lesser of the stated vesting period or the period until the employee becomes retirement eligible, after taking into account forfeitures.
Foreign currency
Financial statements of operations for which the U.S. dollar is not the functional currency are translated to the U.S. dollar prior to consolidation. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date, while income statement accounts are translated at the average exchange rate for each period. For these operations, translation gains and losses are recorded as a component of accumulated other comprehensive loss in stockholders’ equity until the foreign entity is sold or liquidated.
Derivative financial instruments
The Company uses derivative financial instruments to hedge its exposures to various risks, including foreign currency exchange rate risk. The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates. The Company’s major foreign currency exposures involve the markets in Western Europe, South America and Asia. Some sales and purchase contracts contain embedded derivatives due to the nature of doing business in certain jurisdictions, which the Company takes into consideration as part of its risk management policy. The purpose of foreign currency hedging activities is to manage the economic impact of exchange rate volatility associated with anticipated foreign currency purchases and sales made in the normal course of business. Forward foreign exchange contracts with maturities of less than one year are primarily utilized in managing this foreign exchange rate risk. The Company does not enter into derivative financial instruments solely for speculative purposes.
Derivatives are recognized in the Consolidated Balance Sheets at fair value, with classification as current or non-current based upon the maturity of the derivative instrument. The Company does not offset fair value amounts for derivative instruments held with the same counterparty. Changes in the fair value of derivative instruments are recorded in current earnings or deferred in accumulated other comprehensive loss, depending on the type of hedging transaction and whether a derivative is designated as, and is effective as, a hedge.
In the Consolidated Statements of Income, earnings from foreign currency derivatives related to sales and remeasurement of sales-related assets, liabilities and contracts are recorded in revenue, while earnings from foreign currency derivatives related to purchases and remeasurement of purchase-related assets, liabilities and contracts are recorded in cost of products. Earnings from foreign currency derivatives related to cash management of foreign currencies throughout the world and remeasurement of cash are recorded in selling, general and administrative expenses. Changes in the fair value of deal-contingent forward contracts related to the foreign currency dominated purchase price of current or potential business combinations are recorded in selling, general and administrative expenses.
When hedge accounting is applied, the Company ensures that the derivative is highly effective at offsetting changes in anticipated cash flows of the hedged item or transaction. Changes in fair value of derivatives that are designated as cash flow hedges are deferred in accumulated other comprehensive income (loss) until the underlying transactions are recognized in earnings. At such time, related deferred hedging gains or losses are also recorded in earnings on the same line as the hedged item. Effectiveness is assessed at the inception of the hedge. The Company documents the risk management strategy and method for assessing hedge effectiveness at the inception of and throughout the term of each hedge.
The Company uses cross-currency swaps to hedge portions of its net investments denominated in Euro against the effect of adverse foreign exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The Company’s cross-currency swap agreements designated as net investment hedges for accounting purposes synthetically swap U.S. dollar denominated fixed rate debt for Euro denominated fixed rate debt. The gains or losses on these derivative instruments are included in the foreign currency translation component of other comprehensive income until the net investment is sold, diluted, or liquidated. Interest payments received for the cross currency swaps are excluded from the net investment hedge effectiveness assessment and are recorded in interest income on the Consolidated Statements of Income.
The Company uses cross-currency swaps to hedge its foreign currency exchange rate risk related to the portion of the U.S. dollar denominated Term Loan B drawn down by JBT Marel’s European entity. These cross-currency swap agreements designated as fair value hedges for accounting purposes synthetically swap interest rates from SOFR to EURIBOR and hedge the impact of variability in exchange rates on the U.S. dollar dominated debt and related interest payments, excluding the credit spread, by our euro-functional entity. The gains and losses related to the change in the fair value of the hedged components of the swaps are included in other income in the Consolidated Statements of Income and substantially offset the change in the fair value of the hedged portion of the underlying debt that is attributable to the change in euro to U.S. dollar exchange rates.
For derivatives with components excluded from the assessment of hedge effectiveness, the accumulated gains or losses recorded in accumulated other comprehensive income (loss) on such excluded components in a qualifying cash flow or net investment hedging relationship are reclassified to earnings on a systematic and rational basis over the hedge term.
Cash flows from derivative contracts are reported in the consolidated statements of cash flows in the same categories as the cash flows from the underlying transactions.
Leases
Lessee accounting
The Company leases office space, manufacturing facilities and various types of manufacturing and data processing equipment. Leases of real estate generally provide that the Company pays for repairs, property taxes and insurance. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on whether the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are included in operating lease right of use (“ROU”) assets, other current liabilities, and operating lease liabilities in the Consolidated Balance Sheets, which are reported within other assets, other current liabilities and other liabilities, respectively. Lease liabilities are classified between current and long-term liabilities based on their payment terms. The ROU asset balance for finance leases is included in property, plant, and equipment, net in the Consolidated Balance Sheets. In accordance with the standard, the Company has elected not to recognize leases with terms of less than one year on the Consolidated Balance Sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the implicit rate is generally not readily determinable for most of its leases, the Company uses its incremental borrowing rate at commencement date in determining the present value of lease payments. We determine the incremental borrowing rate for all leases, based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses an unsecured borrowing rate and risk-adjusts that rate to approximate a collateralized rate. The operating lease ROU asset also includes prepaid rent and reflects the unamortized balance of lease incentives. Lease expense for operating leases is recognized on a straight-line basis over the lease term.
The Company does not separate lease and non-lease components for leases other than leases of vehicles and communication equipment. For the asset categories of real estate, manufacturing, office and IT equipment, the Company accounts for the lease and non-lease components as a single lease component.
The Company’s leases may include renewal and termination options, which extend the lease term if the Company concludes that it is reasonably certain that it will exercise the option. The exercise of lease renewal options is at the Company’s sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of the ROU assets are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the Consolidated Statements of Income.
The Company’s lease agreements do not contain any material residual value guarantees.
Lessor accounting
The Company leases certain equipment, such as high capacity industrial extractors, to customers.
In most instances, the Company includes maintenance as a component of the lease agreement. Lease accounting requires lessors to separate lease and non-lease components and further defines maintenance as a non-lease component. The Company combines lease and non-lease components where the components meet both of the following criteria:
•The timing and pattern of transfer to the lessee of the lease and non-lease component are the same, and
•The lease component, if accounted for separately, would be classified as an operating lease.
As such, the leased asset and its respective maintenance component are accounted for as a single component.
In certain leases, consumables are included as a non-lease component. For these leases, the components do not qualify for the practical expedient as the timing and pattern of transfer to the lessee are not the same. In these instances, the non-lease component will be accounted for in accordance with ASC 606.
The Company monitors the risk associated with residual value of its leased assets. It reviews on an annual basis or more often as deemed necessary, and adjusted residual values and useful lives of equipment leased to outside parties, as appropriate. Adjustments to residual values result in an adjustment to depreciation expense. The Company’s annual review is based on a long-term view considering historical market price changes, market price trends, and expected life of the equipment.
Lease agreements with the Company’s customers do not contain any material residual value guarantees. Certain lease agreements include terms and conditions resulting in variable lease payments. These payments typically rely upon the usage of the underlying asset.
Certain lease agreements provide renewal options, including some leases with an evergreen renewal option. The exercise of the lease renewal option is at the sole discretion of the lessee. In most instances, the lease can only be terminated in cases of breach of contract. In these instances, termination fees do not apply. Certain lease agreements also allow the lessee to purchase the leased asset at fair market value or a specific agreed upon price. The exercise of the lease purchase option is at the sole discretion of the lessee.
Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 amends ASC 740, Income Taxes to expand income tax disclosures and requires that the Company disclose (i) the income tax rate reconciliation using both percentages and reporting currency amounts; (ii) specific categories within the income tax rate reconciliation; (iii) additional information for reconciling items that meet a quantitative threshold; (iv) the composition of state and local income taxes by jurisdiction; and (v) the amount of income taxes paid disaggregated by jurisdiction. The Company adopted ASU 2023-09 for the year ended December 31, 2025 on a prospective basis. See Note 9. Income Taxes for additional information.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024-03”), that requires disclosures of disaggregated information about certain income statement expense line items on an annual and interim basis. This standard will be effective for fiscal years beginning after December 15, 2026, with early adoption permitted, and will be applied prospectively, with the option to apply retrospectively. The Company is evaluating the impact of adopting this standard and currently expects ASU 2024-03 to impact its disclosures only.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326) (“ASU 2025-05”), which provides a practical expedient to measure credit losses on current accounts receivable and current contract assets. The practical expedient allows companies to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset when measuring credit losses. The standard will be effective for the fiscal year beginning January 1, 2026 and for interim periods beginning on and after January 1, 2026, with early adoption permitted. The Company does not expect ASU 2025-05 to have a material impact on its financial statements.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) (“ASU 2025-06”). The amendment modernizes the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introduces a more judgment-based approach. ASU 2025-06 will be effective for the fiscal year beginning January 1, 2028, and for interim periods beginning in that fiscal year, with early adoption permitted as of the beginning of a fiscal year. The standard may be applied prospectively, retrospectively, or through a modified prospective transition method. The Company is in the process of evaluating the impact of ASU 2025-06 on its financial statements.
NOTE 2. ACQUISITIONS
On January 2, 2025, the Company acquired 97.5% of the equity interests of Marel (“Marel”), a public limited liability company incorporated under the laws of Iceland, for $4,182.3 million, which is net of cash acquired of $90.0 million (the “Marel Transaction”). Marel is a global provider of advanced processing equipment, systems, software and services, primarily for the poultry, meat, and fish industries, as well as a provider of processing solutions for pet food, plant-based proteins and aqua feed, with a presence in over 30 countries. The purpose of the acquisition of Marel was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide.
As part of the Marel Transaction, the Company settled Marel's outstanding debt of $867.8 million. In addition, the Company amended its existing credit facility in conjunction with the acquisition. The Second Amended and Restated Credit Agreement provides for a $1.8 billion revolving credit facility, which matures on January 2, 2030, and a $900.0 million Senior Secured Term Loan B, which matures on January 2, 2032. The proceeds from these facilities were used to fund the cash consideration for the acquisition and to settle the outstanding debt of Marel at the acquisition date.
The consideration transferred to Marel shareholders on the acquisition date consisted of the following:
| | | | | |
| (In millions, except per share data and exchange rates) | |
| JBT shares issued to Marel shareholders | 19.5 | |
| JBT share price on January 2, 2025 | $ | 124.94 | |
| Value of JBT shares issued to Marel shareholders | $ | 2,436.3 | |
| Cash consideration to Marel shareholders (in €) | € | 926.6 | |
| EUR to USD Exchange Rate | 1.0353 €/$ |
| Cash consideration to Marel shareholders (in $) | $ | 959.3 | |
| Settlement of Marel debt | $ | 867.8 | |
| Settlement of Marel interest rate swaps | $ | 3.3 | |
| Fair value of Marel stock options attributable to pre-combination vesting | $ | 5.6 | |
| Purchase consideration | $ | 4,272.3 | |
This acquisition has been accounted for as a business combination. Tangible and identifiable intangible assets acquired and liabilities assumed were recorded at their respective estimated fair values. The excess consideration over the estimated fair value of the net assets received has been recorded as goodwill. The factors that contributed to the recognition of goodwill primarily relate to acquisition-driven anticipated cost savings and revenue enhancement synergies coupled with the assembled workforce acquired. Assembled workforce is not recognized separate and apart from goodwill as it is neither separable nor contractual in nature. Goodwill created as a result of the Marel acquisition is not deductible for tax purposes.
Marel had revenue of $2,021.1 million and generated operating income of $119.4 million for the period from the acquisition date through December 31, 2025.
Acquisition-related transaction costs totaling $57.9 million were recorded as Selling, general and administrative expense in the Consolidated Statements of Income during the year ended December 31, 2025.
The following table summarizes the fair values recorded for the assets acquired and liabilities assumed for Marel:
| | | | | | | | | | | | | | | | | |
| (In millions) | Preliminary Purchase Price Allocation | | Measurement Period Adjustments(1) | | Final Purchase Price Allocation |
| Financial assets | $ | 401.8 | | | $ | 0.4 | | | $ | 402.2 | |
| Inventories | 344.4 | | | (2.3) | | | 342.1 | |
| Property, plant and equipment | 492.6 | | | 61.2 | | | 553.8 | |
| Right-of-use assets | 42.3 | | | (5.6) | | | 36.7 | |
| Customer relationship | 1,570.0 | | | (410.0) | | | 1,160.0 | |
| Acquired technology | 410.0 | | | (40.0) | | | 370.0 | |
| Trademarks | 260.0 | | | (30.0) | | | 230.0 | |
| Deferred taxes | (514.9) | | | 112.3 | | | (402.6) | |
| Financial liabilities | (630.0) | | | (25.9) | | | (655.9) | |
| Total identifiable net assets | $ | 2,376.2 | | | $ | (339.9) | | | $ | 2,036.3 | |
| | | | | |
| Purchase consideration | $ | 4,272.3 | | | $ | — | | | $ | 4,272.3 | |
| | | | | |
Noncontrolling interest(2) | $ | 86.0 | | | $ | — | | | $ | 86.0 | |
| | | | | |
| Goodwill | $ | 1,982.1 | | | $ | 339.9 | | | $ | 2,322.0 | |
(1) During the measurement period, the Company recorded measurement period adjustments to the purchase price allocation as it obtained information and completed its valuation of certain assets and liabilities. The impact of these adjustments was reflected as a net increase in goodwill. Adjustments to the fair values of inventories, property, plant and equipment, and acquired intangible assets during the measurement period would have resulted in higher amortization expense by $2.8 million and lower amortization expense by $5.8 million during the quarters ended March 31, 2025 and June 30, 2025, respectively.
(2) The Company acquired 97.5% of the equity interests of Marel and recognized a non-controlling interest in Marel on the acquisition date. The non-controlling interest was recognized at fair value, which was estimated based upon the trading price of the Company’s common stock on the acquisition date and the types of consideration that non-controlling interest holders were eligible to receive. The Company subsequently acquired the remaining 2.5% of Marel’s equity interests, as described below.
The acquired intangible assets are amortized on a straight-line basis over their estimated useful lives. The intangible assets acquired have estimated useful lives of 16 years for customer relationships, 21 years for acquired technology, and 26 years for trademarks.
The allocation of the purchase price presented above was based on the fair values of the acquired assets and assumed liabilities using valuation techniques including the income, market, and cost approaches.
During the fourth quarter of 2025, the Company completed its valuation of the assets acquired and liabilities assumed and aligned certain accounting policies, including the accounting for research and development expenses. As a result, the Company recorded final adjustments to the provisional amounts as of December 31, 2025.
Pro forma financial information (unaudited)
The following information reflects the results of the Company’s operations for the years ended December 31, 2025 and 2024 on a pro forma basis as if the acquisition of Marel had been completed on January 1, 2024. Pro forma adjustments have been made to illustrate the impact of incremental non-recurring acquisition-related costs totaling $53.1 million, and the incremental impact on earnings of interest costs on the borrowings to acquire the company, amortization expense related to acquired intangible assets, depreciation expense related to the fair value of the acquired depreciable tangible assets, and the related tax impact associated with these adjustments.
| | | | | | | | | | | |
| Year Ended December 31, |
| (In millions, except per share data) | 2025 | | 2024 |
| Revenue | | | |
| Pro forma | $ | 3,798.2 | | | $ | 3,436.6 | |
Income (loss) from continuing operations | | | |
| Pro forma | $ | 11.7 | | | $ | (104.5) | |
The unaudited pro forma information is provided for illustrative purposes only and does not purport to represent what the Company's consolidated results of operations would have been had the transaction actually occurred as of January 1, 2024, and does not purport to project actual consolidated results of operations.
Acquisition of non-controlling interest of Marel
On February 4, 2025, the Company acquired the remaining 2.5% of Marel’s equity interests that were not acquired through the Marel Transaction, for approximately $88.7 million. The total purchase consideration was comprised of approximately $64.3 million in equity consideration and $24.4 million in cash consideration. This transaction was accounted for as an equity transaction and was reflected within financing activities within the Consolidated Statements of Cash Flows.
NOTE 3. DISCONTINUED OPERATIONS
As disclosed in Note 1, on August 1, 2023, the Company completed the sale of AeroTech to the Purchaser in exchange for cash consideration of $808.2 million. The Company recognized a gain on the Transaction of $443.7 million, net of $131.4 million of income taxes on the transaction, which is recognized in Income from discontinued operations within the Consolidated Statements of Income for the year ended December 31, 2023. Income taxes on the transaction were reduced by $17.9 million, driven by a tax benefit allocated to discontinued operations from the sale of a subsidiary in the period ending December 31, 2023. The sale of AeroTech allowed the Company to become a pure-play food and beverage solutions provider.
In connection with the Transaction, the Company and the Purchaser entered into a Transition Services Agreement (the “TSA”) for the provision of information technology related services for 12 months and of other services for 6 months to support the transition of the AeroTech business. Services under the TSA effectively concluded in the quarter ended September 30, 2024. TSA income was recognized as services were performed, and the income earned was recorded in Selling, general and administrative expense within the Consolidated Statements of Income to offset the costs incurred to support the TSA. During the year ended December 31, 2024, the Company’s cash inflows from the Purchaser related to the TSA were $5.0 million.
Summarized Discontinued Operations Financial Information
The following table summarizes the results of operations classified as discontinued operations, net of taxes, in the Consolidated Statements of Income for the year ended December 31, 2023. | | | | | |
| (In millions) | 2023 |
| Revenue | $ | 344.1 | |
| Operating expenses: | |
| Cost of sales | 285.3 | |
| Selling, general and administrative expense | 45.3 | |
| Operating income | 13.5 | |
| Interest expense | 2.0 | |
| Gain on sale of AeroTech | 557.2 | |
| Income from discontinued operations before income taxes | 568.7 | |
| Income tax provision | 115.4 | |
| Income from discontinued operations, net of taxes | $ | 453.3 | |
In accordance with ASC 205-20, Allocation of Interest to Discontinued Operations, the Company elected to allocate interest expense to discontinued operations for the Company’s debt that is not directly attributed to the AeroTech business. Interest expense was allocated based on a ratio of net assets of discontinued operations to the sum of consolidated net assets and consolidated debt.
NOTE 4. INVENTORIES
Inventories as of December 31, consisted of the following:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Raw materials | $ | 218.0 | | | $ | 37.3 | |
| Work in process | 82.0 | | | 50.2 | |
| Finished goods | 375.1 | | | 164.9 | |
| Gross inventories before valuation adjustments | 675.1 | | | 252.4 | |
| Valuation adjustments | (31.4) | | | (19.3) | |
| Net inventories | $ | 643.7 | | | $ | 233.1 | |
NOTE 5. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment as of December 31, consisted of the following:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Land and land improvements | $ | 23.3 | | | $ | 15.1 | |
| Buildings | 489.4 | | | 120.4 | |
| Machinery and equipment | 634.1 | | | 403.1 | |
| Construction in process | 38.7 | | | 15.5 | |
| 1,185.5 | | | 554.1 | |
| Accumulated depreciation | (392.1) | | | (320.4) | |
| Property, plant and equipment, net | $ | 793.4 | | | $ | 233.7 | |
NOTE 6. OTHER ASSETS
Other assets as of December 31, consisted of the following:
| | | | | | | | | | | | | | | | | | | | | | | |
| 2025 | | 2024 |
| (In millions) | Carrying Amount | | Accumulated Amortization | | Carrying Amount | | Accumulated Amortization |
| Capitalized software | $ | 187.8 | | | $ | 84.7 | | | $ | 121.9 | | | $ | 60.3 | |
| Cloud computing arrangement implementation costs | 33.1 | | | 15.6 | | | 32.5 | | | 13.5 | |
| Other | 143.0 | | | — | | | 126.2 | | | — | |
| Total other assets | $ | 363.9 | | | $ | 100.3 | | | $ | 280.6 | | | $ | 73.8 | |
Capitalized software amortization expense was $26.9 million, $13.2 million, and $14.4 million for 2025, 2024, and 2023, respectively. Amortization expense related to cloud computing arrangement implementation costs was $4.9 million, $4.2 million, and $2.2 million for 2025, 2024, and 2023, respectively.
NOTE 7. GOODWILL AND INTANGIBLE ASSETS
Following the acquisition of Marel on January 2, 2025, we operated through two segments, JBT and Marel, which were comprised of the legacy operations of each business. During the fourth quarter of 2025, we realigned our reportable segments to better reflect the integration of our new operating model. We now operate through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions.
As a result of our segment realignment, the composition of our reporting units changed. Under ASC 350, Intangibles—Goodwill and Other, the goodwill previously assigned to the JBT and Marel reportable segments were reassigned to the new reporting units within the Protein Solutions and Prepared Food and Beverage Solutions reportable segments.
This reallocation was performed based on the relative fair value of the assets moved to the new reporting units on the realignment effective date in the fourth quarter of 2025.
The changes in the carrying amount of goodwill by reportable segment were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (In millions) | JBT | | Marel | | Protein Solutions | | Prepared Food and Beverage Solutions | | Total |
| Balance as of January 1, 2024 | $ | 779.5 | | | $ | — | | | $ | — | | | $ | — | | | $ | 779.5 | |
| Currency translation | (10.4) | | | — | | | — | | | — | | | (10.4) | |
| Balance as of December 31, 2024 | 769.1 | | | — | | | — | | | — | | | 769.1 | |
| Acquisitions | — | | | 2,322.0 | | | — | | | — | | | 2,322.0 | |
Currency translation | 19.2 | | | 275.5 | | | 33.2 | | | 9.4 | | | 337.3 | |
Reallocation due to reorganization | (788.3) | | | (2,597.5) | | | 2,273.0 | | | 1,112.8 | | | — | |
| Balance as of December 31, 2025 | $ | — | | | $ | — | | | $ | 2,306.2 | | | $ | 1,122.2 | | | $ | 3,428.4 | |
The Company completed its annual goodwill impairment test as of October 31, 2025 using a qualitative assessment and determined that it was more likely than not that the fair value of each reporting unit exceeded its carrying value, and therefore concluded that none of its goodwill was impaired. Similar conclusions were reached for all reporting units as of October 31, 2024 and 2023.
Due to the segment realignment as described above, the Company performed an interim quantitative assessment of goodwill in accordance with ASC 350 in the fourth quarter of 2025. The assessment utilized an income approach (discounted cash flow model) and compared the fair value of each reporting unit to its carrying value, including the allocated goodwill. Based on the results of this assessment, the Company determined that the fair value of each reporting unit exceeded its carrying value, and concluded that none of its goodwill was impaired on the date of realignment.
Intangible assets consisted of the following:
| | | | | | | | | | | | | | | | | | | | | | | |
| 2025 | | 2024 |
| (In millions) | Carrying Amount | | Accumulated Amortization | | Carrying Amount | | Accumulated Amortization |
| Customer relationships | $ | 1,690.8 | | | $ | 284.6 | | | $ | 421.3 | | | $ | 170.6 | |
| Patents and acquired technology | 590.2 | | | 165.0 | | | 169.8 | | | 123.1 | |
| Trademarks | 313.4 | | | 33.5 | | | 53.2 | | | 20.0 | |
| Indefinite lived intangibles assets | 10.7 | | | — | | | 10.3 | | | — | |
| Other | 10.9 | | | 10.7 | | | 8.6 | | | 8.6 | |
| Total intangible assets | $ | 2,616.0 | | | $ | 493.8 | | | $ | 663.2 | | | $ | 322.3 | |
Intangible asset amortization expense was $151.9 million, $44.6 million, and $46.1 million for 2025, 2024 and 2023, respectively. Annual amortization expense for intangible assets is estimated to be $140.5 million in 2026, $137.0 million in 2027, $134.2 million in 2028, $130.9 million in 2029, and $128.4 million in 2030.
NOTE 8. DEBT
The components of the Company’s borrowings as of December 31, were as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | Maturity Date | | 2025 | | 2024 |
Revolving credit facility (1) | January 2, 2030 | | $ | 37.6 | | | $ | 854.0 | |
| Less: unamortized debt issuance costs | | | (0.1) | | | (1.3) | |
| Revolving credit facility, net | | | 37.5 | | | 852.7 | |
| | | | | |
Senior Secured Term Loan B (2) | January 2, 2032 | | 893.2 | | | — | |
| Less: unamortized debt issuance costs | | | (12.8) | | | — | |
| Senior Secured Term Loan B, net | | | 880.4 | | | — | |
| | | | | |
2030 Convertible senior notes (3) | September 15, 2030 | | 575.0 | | | — | |
| Less: unamortized debt issuance costs | | | (14.7) | | | — | |
| Convertible senior notes, net | | | 560.3 | | | — | |
| | | | | |
2026 Convertible senior notes (4) | May 15, 2026 | | 402.5 | | | 402.5 | |
| Less: unamortized debt issuance costs | | | (0.8) | | | (3.1) | |
| Convertible senior notes, net | | | 401.7 | | | 399.4 | |
| | | | | |
Other (5) | | | 2.0 | | | — | |
| | | | | |
| Total debt, including current portion | | | 1,881.9 | | | 1,252.1 | |
| Less: current portion of debt | | | 411.9 | | | — | |
| Long-term debt, net | | | $ | 1,470.0 | | | $ | 1,252.1 | |
(1) Weighted-average interest rate at December 31, 2025 was 3.40%
(2) Effective interest rate for the Term Loan B (as defined below) for the quarter ended December 31, 2025 was 5.76%
(3) Effective interest rate for the 2030 Notes (as defined below) for the quarter ended December 31, 2025 was 0.93%.
(4) Effective interest rate for the 2026 Notes (as defined below) for the quarter ended December 31, 2025 was 0.82%.
(5) Overdraft facility and foreign line of credit borrowing.
The Company had access to short-term financing of $45.5 million and $8.0 million as of December 31, 2025 and December 31, 2024, respectively.
Components of interest expense recognized for the Senior Secured Term Loan B (the “Term Loan B”), the 0.375% Convertible Senior Notes due 2030 (the “2030 Notes”), and the 0.25% Convertible Senior Notes due 2026 (the “2026 Notes” and, together with the 2030 Notes, the “Notes”) were as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Contractual interest expense, Term Loan B | $ | 57.2 | | | $ | — | | | $ | — | |
| Interest cost related to amortization of issuance costs, Term Loan B | 2.0 | | | — | | | — | |
| Total interest expense, Term Loan B | $ | 59.2 | | | $ | — | | | $ | — | |
| Contractual interest expense, the Notes | $ | 1.7 | | | $ | 1.0 | | | $ | 1.0 | |
| Interest cost related to amortization of issuance costs, the Notes | 3.2 | | | 2.2 | | | 2.2 | |
| Total interest expense, the Notes | $ | 4.9 | | | $ | 3.2 | | | $ | 3.2 | |
Five-year Revolving Credit Facility
On January 2, 2025, the Company executed the Second Amended and Restated Credit Agreement (the “Second A&R Credit Agreement”), which provides for a $1.8 billion revolving credit facility that matures on January 2, 2030; provided that if (1) any of the Company’s 2026 Notes remain outstanding on the date that is 91 days prior to the maturity date of the 2026 Notes (the “Springing Maturity Date”), (2) the aggregate principal amount of the 2026 Notes outstanding on such date exceeds $100 million and (3) the sum of the aggregate availability under the revolving credit facility on such date plus the aggregate amount of unrestricted cash of the Company and its subsidiaries on such date is less than $600 million, then the maturity date with respect to the revolving credit facility shall be the Springing Maturity Date.
Under the Second A&R Credit Agreement, the Company is subject to a maximum Secured Net Leverage Ratio (as defined in the Second A&R Credit Agreement) for the first 12 months after the closing of the Marel Transaction of 5.00 to 1.00, stepping down to 4.00 to 1.00 at 12 months after the closing of the Marel Transaction and further stepping down to 3.50 to 1.00 at 18 months after the closing of the Marel Transaction. Among other things, the Second A&R Credit Agreement allows the Company the option to temporarily increase the maximum allowable Secured Net Leverage Ratio to 4.00 to 1.00 following the completion of a permitted acquisition, or a series of permitted acquisitions within a 12-month period (other than the Marel Transaction), having aggregate consideration in excess of $100 million (the “Leverage Ratio Increase Option”). If exercised, the Leverage Ratio Increase Option will remain in effect for four consecutive fiscal quarters (beginning with the quarter in which the permitted acquisition, or the last permitted acquisition in a series of permitted acquisitions for aggregate consideration in excess of $100 million, is consummated), unless revoked earlier by the Company.
The Second A&R Credit Agreement also provides that, solely with respect to the revolving credit facility thereunder, the Company is subject to an Interest Coverage Ratio (as defined in the Second A&R Credit Agreement) of not less than: (a) Consolidated EBITDA (as defined in the Second A&R Credit Agreement) to (b) Consolidated Interest Expense (as defined in the Second A&R Credit Agreement), in each case for the period of four consecutive fiscal quarters ending with the end of such fiscal quarter, all calculated for the Company and its subsidiaries on a consolidated basis, to be less than: (1) for the first 18 months after the closing date of the Marel Transaction, 2.50 to 1.00 and (2) thereafter, 3.00 to 1.00.
On September 3, 2025, the Company entered into the Second Amendment to the Second A&R Credit Agreement (the “Second Amendment”) in order to reduce the pricing applicable to the revolving credit facility. Under the Second Amendment, revolving loans bear interest, at the Company’s option, at (1) the applicable borrowing rate (i.e. SOFR or EURIBOR) (subject to a floor rate of zero), or (2) an alternate base rate (which is the greater of Wells Fargo’s Prime Rate, the Federal Funds Rate plus 0.5%, or SOFR (subject to a floor rate of zero) plus 1.0%), plus, in each case, a margin dependent on the leverage ratio.
The Company is required to make periodic interest payments on borrowed amounts and to pay an annual commitment fee of 15.0 to 25.0 basis points, depending on its leverage ratio, based on the unused portion of the Credit Facility. As of December 31, 2025, the Company had $37.6 million drawn on and $1,756.4 million of availability under the revolving credit facility. The ability to use this availability is limited by the leverage ratio covenant described below.
The obligations under the Credit Agreement are guaranteed by the Company’s domestic and certain foreign subsidiaries and subsequently formed or acquired subsidiaries (the “Guarantors”). The obligations under the Credit Agreement are secured by a first-priority security interest in substantially all of the Guarantor’s tangible and intangible personal property and a pledge of the capital stock of permitted borrowers and certain Guarantors.
The Company's credit facility includes restrictive covenants that, if not met, could lead to renegotiation of its credit facility, a requirement to repay its borrowings, and/or a significant increase in its cost of financing. Restrictive covenants include a minimum interest coverage ratio, a maximum leverage ratio, as well as certain events of default.
Senior Secured Term Loan B
On January 2, 2025, the Company entered into a $900 million Senior Secured Term Loan B under the Second A&R Credit Agreement (the “Term Loan B”), which matures on January 2, 2032. The Company is required to make quarterly principal repayments equal to 0.25% of the initial Term Loan B.
On August 20, 2025, the Company entered into the First Amendment to the Second A&R Credit Agreement (the “First Amendment”), in order to reduce the pricing applicable to the Term Loan B. Borrowings under the Term Loan B bear interest at the greater of (1) SOFR (subject to a floor rate of zero) or (2) a floor of 0%, plus an applicable margin of 1.75%.
Bridge Credit Agreement
In connection with the Marel Transaction, on April 4, 2024, the Company entered into a bridge credit agreement with certain financial institutions (the "Bridge Credit Agreement") that committed to provide the Company with secured bridge financing in an aggregate principal amount of €1.9 billion. Upon the completion of the Marel Transaction on January 2, 2025, the Bridge Credit Agreement was terminated. Accordingly, the Company fully amortized the remaining related financing costs that were capitalized as of December 31, 2024.
During 2025 and 2024, the Company recognized $12.4 million and $7.1 million, respectively, of financing costs associated with the Bridge Credit Agreement, in Interest expense in the Consolidated Statements of Income.
2030 Convertible Senior Notes
On September 9, 2025, the Company closed a private offering of $575.0 million aggregate principal amount of the Company’s 0.375% Convertible Senior Notes due 2030 to qualified institutional buyers, resulting in net proceeds of approximately $562.5 million after deducting initial purchasers’ discounts. Interest on the 2030 Notes will accrue from September 9, 2025 and is payable semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026, at a rate of 0.375% per year. The 2030 Notes will mature on September 15, 2030 unless earlier converted, redeemed or repurchased. No sinking fund is provided for the 2030 Notes.
The initial conversion rate of the 2030 Notes is 5.3258 shares of the Company’s common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $187.77 per share. The conversion rate of the 2030 Notes is subject to adjustment upon the occurrence of certain specified events. In addition, upon the occurrence of a make-whole fundamental change (as defined in the indenture governing the 2030 Notes (the “Indenture”)) or upon a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder that elects to convert its 2030 Notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.
On or after September 20, 2028, the Company has the option to redeem for cash all or any portion of the 2030 Notes if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2030 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding 2030 Notes, at least $100 million aggregate principal amount of 2030 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.
Prior to the close of business on the business day immediately preceding June 15, 2030, the 2030 Notes are convertible at the option of the holders only under the following circumstances:
•during any calendar quarter commencing after the calendar quarter ending on December 31, 2025 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
•during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of 2030 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day;
•if the Company calls such 2030 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the notes called (or deemed called) for redemption; or
•upon the occurrence of certain corporate events, as specified in the Indenture.
At any time on or after June 15, 2030, holders may convert their 2030 Notes at their option, and in multiples of $1,000 principal amount, without regard to the foregoing circumstances. Upon conversion, the Company will pay cash up to the aggregate principal amount of the 2030 Notes and for the remainder of the Company’s conversion obligation in excess of the aggregate principal amount will pay or deliver cash, shares of common stock, or a combination of cash and shares of common stock at the Company’s election.
Upon the occurrence of a fundamental change (as defined in the Indenture), subject to certain conditions, the holders of the 2030 Notes may require the Company to repurchase for cash all or any portion of their 2030 Notes in multiples of $1,000 principal amounts, at its repurchase price, plus accrued and unpaid interest to, but excluding the repurchase date.
The 2030 Notes were not convertible during the year ended December 31, 2025 and none have been converted to date. Given the average market price of the common stock has not exceeded the exercise price since inception, there is no impact to the diluted earnings per share.
The Notes are senior unsecured obligations and rank equally in right of payment with all of the Company’s existing and unsubordinated debt and senior in right of payment to any future debt that is expressly subordinated in right of payment to the Notes.
The Notes will be effectively subordinated to any of the Company’s existing and future secured debt to the extent of the assets securing such indebtedness.
The Indenture includes customary terms and covenants, including certain events of default after which the 2030 Notes may become due and payable immediately.
The Company recognized $15.6 million of debt issuance costs associated with the 2030 Notes.
2030 Convertible Note Hedge Transactions
On September 9, 2025, the Company paid an aggregate amount of $105.6 million for convertible note hedge transactions entered into in connection with the issuance of the 2030 Notes (the “2030 Hedge Transactions”). The 2030 Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the 2030 Notes, approximately 3.1 million shares of the Company’s common stock, which is the same number of shares initially underlying the 2030 Notes, at a strike price of $187.77, subject to customary adjustments. The 2030 Hedge Transactions will expire upon the maturity of the 2030 Notes, subject to earlier exercise or termination.
The 2030 Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the 2030 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the converted 2030 Notes, in the event that the market price per share of the Company’s common stock, as measured under the terms of the 2030 Hedge Transactions, is greater than the 2030 Hedge Transactions strike price of $187.77. The 2030 Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders’ Equity, and therefore these transactions are not revalued after their issuance.
The Company made a tax election to integrate the 2030 Notes and the 2030 Hedge Transactions. The accounting impact of this tax election makes the 2030 Hedge Transactions deductible as original issue discount interest for tax purposes over the term of the 2030 Notes, and results in a $26.9 million deferred tax asset recorded as an adjustment to Additional paid-in capital on our Consolidated Balance Sheet as of December 31, 2025.
2026 Convertible Senior Notes
On May 28, 2021, the Company closed a private offering of $402.5 million aggregate principal amount of the Company's 0.25% Convertible Senior Notes due 2026 (the "Notes") to qualified institutional buyers, resulting in net proceeds of approximately $392.2 million after deducting initial purchasers’ discounts of the Notes. Interest on the Notes has accrued from May 28, 2021 and is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2021, at a rate of 0.25% per year. The Notes will mature on May 15, 2026 unless earlier converted, redeemed or repurchased. No sinking fund is provided for the Notes.
The initial conversion rate of the Notes is 5.8958 shares of the Company's common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $169.61 per share. The conversion rate of the Notes is subject to adjustment upon the occurrence of certain specified events. In addition, upon the occurrence of a make-whole fundamental change (as defined in the indenture governing the Notes (the "Indenture")) or upon a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change or notice of redemption, as the case may be.
On or after March 20, 2024, the Company has the option to redeem for cash all or part of the Notes, if the last reported sales price of the Company's common stock (the "common stock") has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides redemption notice, during any 30 consecutive trading days ending on, and including, the last trading day immediately before the date the Company sends the related redemption notice. The redemption price of each Note to be redeemed will be the principal amount of such note, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least $100 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.
Prior to the close of business on the business day immediately preceding February 15, 2026, the Notes are convertible at the option of the holders only under the following circumstances:
•during any calendar quarter commencing after the calendar quarter ending on September 30, 2021 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
•during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day;
•if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or
•upon the occurrence of certain corporate events, as specified in the Indenture governing the Notes.
At any time on or after February 15, 2026, holders may convert their Notes at their option, and in multiples of $1,000 principal amount, without regard to the foregoing circumstances. Upon conversion, the Company will pay cash up to the aggregate principal amount of the Notes and for the remainder of our conversion obligation in excess of the aggregate principal amount will pay or deliver cash, shares of common stock, or a combination of cash and shares of common stock at the Company’s election.
2026 Convertible Note Hedge Transactions
In conjunction with the 2026 Notes, the Company paid an aggregate amount of $65.6 million for the 2026 Convertible Note Hedge Transactions (the "2026 Hedge Transactions"). The 2026 Hedge Transactions cover, subject to anti-dilution adjustments substantially similar to those in the 2026 Notes, approximately 2.4 million shares of the Company's common stock. These are the same number of shares initially underlying the 2026 Notes, at a strike price of $169.61, subject to customary adjustments. The 2026 Hedge Transactions will expire upon the maturity of the 2026 Notes, subject to earlier exercise or termination.
The 2026 Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the 2026 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the converted 2026 Notes, in the event that the market price per share of the Company's common stock, as measured under the terms of the 2026 Hedge Transactions, is greater than the 2026 Hedge Transactions strike price of $169.61. The 2026 Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders' Equity, and therefore these transactions are not revalued after their issuance.
The Company made a tax election to integrate the 2026 Notes and the 2026 Hedge Transactions. The accounting impact of this tax election makes the 2026 Hedge Transactions deductible as original issue discount interest for tax purposes over the term of the note, and resulted in a $17.1 million deferred tax asset recorded as an adjustment to Additional paid-in capital on the Balance Sheet as of December 31, 2025 and 2024.
Warrant Transactions
During the third quarter of 2025 and the second quarter of 2021, concurrently with entering into the 2030 Hedge Transactions and 2026 Hedge Transactions, the Company separately entered into privately-negotiated warrant transactions (the “2030 Warrant Transactions” and the “2026 Warrant Transactions”, respectively), whereby the Company sold to the counterparties warrants to acquire, collectively, subject to anti-dilution adjustments, 3.1 million and 2.4 million shares, respectively, of its common stock at an initial strike price of $283.42 per share and $240.02 per share, respectively. The Company received aggregate proceeds of $51.1 million and $29.5 million from the 2030 Warrant Transactions and the 2026 Warrant Transactions, respectively, with the counterparties, with such proceeds partially offsetting the costs of entering into the 2030 Hedge Transactions and the 2026 Hedge Transactions. The 2030 warrants expire in September 2030 and the 2026 warrants expire in August 2026.
If the market value per share of the common stock exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless the Company elects, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders’ Equity, and therefore the warrants are not revalued after issuance.
NOTE 9. INCOME TAXES
Provision (Benefit) for Income Taxes
Domestic and foreign components of income from continuing operations before income taxes and non-controlling interests for the years ended on December 31, are shown below:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| U.S. | $ | (202.6) | | | $ | (40.8) | | | $ | 65.8 | |
| Non-U.S. | 140.2 | | | 136.1 | | | 87.3 | |
| Income before income taxes | $ | (62.4) | | | $ | 95.3 | | | $ | 153.1 | |
The provision for income taxes related to income from continuing operations for the years ended on December 31, consisted of: | | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Current: | | | | | |
| U.S. federal | $ | 2.5 | | | $ | 1.2 | | | $ | 17.7 | |
| U.S. state and local | 2.1 | | | 2.0 | | | 5.2 | |
| Non-U.S. | 61.9 | | | 33.3 | | | 22.2 | |
| Total current | $ | 66.5 | | | $ | 36.5 | | | $ | 45.1 | |
| Deferred: | | | | | |
| U.S. federal | $ | (35.7) | | | $ | (21.0) | | | $ | (18.9) | |
| U.S. state and local | (14.3) | | | (4.2) | | | (2.9) | |
| Non-U.S. | (29.6) | | | (0.6) | | | 0.2 | |
| Total deferred | $ | (79.6) | | | $ | (25.8) | | | $ | (21.6) | |
| Provision for income taxes | $ | (13.1) | | | $ | 10.7 | | | $ | 23.5 | |
The Company adopted ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on a prospective basis, the table below provides the required disclosure pursuant to ASU 2023-09.
The effective income tax rate for the year ending December 31, 2025 was different from the statutory U.S. federal income tax rate due to the following:
| | | | | | | | | | | |
| (In millions) | Dollar Value ($) | | Percentage of total (%) |
| Provision for income taxes at U.S. federal statutory tax rate | $ | (13.1) | | | 21 | % |
| State and local income tax, net of federal income tax effect | (9.6) | | | 15 | |
| Foreign tax effects | | | |
| Brazil | | | |
| Foreign rate differential | 3.9 | | | (6) | |
| Other | 0.8 | | | (1) | |
| Netherlands | | | |
| Innovation box | (7.0) | | | 11 | |
| Loss on investment | 2.7 | | | (5) | |
| Other | (0.5) | | | 1 | |
| Other foreign jurisdictions | 3.4 | | | (5) | |
| Effect of cross-border tax laws | 2.6 | | | (4) | |
| Tax Credits: | | | |
| Research and development credits | (4.9) | | | 8 | |
| Changes in valuation allowances | 0.2 | | | — | |
| Non-taxable or non-deductible items: | | | |
| Acquisition costs | 7.8 | | | (13) | |
| Other | (1.4) | | | 2 | |
| Changes in unrecognized tax benefits | 2.0 | | | (3) | |
| Total tax provision and effective tax rate | $ | (13.1) | | | 21 | % |
State taxes in Kansas, California, Illinois, Georgia, Florida, Wisconsin, Arkansas, and Iowa make up the majority (greater than 50 percent) of the tax effect in this category.
The effective tax rate reconciliation includes a single line item for unrecognized tax positions, which reflects changes in unrecognized tax benefits arising from tax positions taken in the current year as well as changes related to prior year tax positions, including settlements, lapses of statutes of limitations, and changes in judgment. These impacts are presented on an aggregated basis in accordance with ASU 2023-09.
The table below presents the required disclosure prior to the Company’s adoption of ASU 2023-09. The effective income tax rate for the years ending December 31, 2024 and 2023 differs from the statutory U.S. federal income tax rate due to the following:
| | | | | | | | | | | |
| 2024 | | 2023 |
| Statutory U.S. federal tax rate | 21% | | 21% |
| Net difference resulting from: | | | |
| Research and development tax incentives | (8) | | (5) |
| Foreign earnings subject to different tax rates | 5 | | 2 |
| State income taxes | (1) | | 2 |
| Foreign tax credits | (14) | | (5) |
| US foreign inclusions | 14 | | 6 |
| Stock based compensation - excess tax benefit | 1 | | — |
| Remeasurement of deferred tax liability | (9) | | — |
| Valuation allowance | (1) | | 3 |
| Disposition of subsidiary | — | | (7) |
| Executive Compensation | 2 | | — |
| Other | 1 | | (2) |
| Total difference | (10)% | | (6)% |
| Effective income tax rate | 11% | | 15% |
On July 4, 2025, the United States Congress reconciliation bill commonly referred to as the One Big Beautiful Bill Act (“OBBB”) was signed into law. The Company does not expect any material changes to its financial position, operations, or existing liabilities from the enactment of OBBB. The largest impact the Company currently expects from the tax law changes included in OBBB is a reduction in U.S. research and development credits for 2025 and future years. The expected impact on the Company in 2025 is a reduction in U.S. research and development credits of $1.0 million. The Company will continue to evaluate current and future period effects of the OBBB as additional guidance and regulations are issued.
The Company files income tax returns in the U.S. and foreign jurisdictions. The Company is generally subject to examination by the IRS for years 2022 and later. In addition to the U.S., the Company has tax years that remain open and subject to examination by tax authorities in the following major taxing jurisdictions: Sweden for years after 2023, Brazil for years after 2020, and the Netherlands for years after 2020.
Deferred Income Taxes
Significant components of deferred tax assets and liabilities at December 31, were as follows:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Deferred tax assets attributable to: | | | |
| Accrued pension and other postretirement benefits | $ | 6.9 | | | $ | 5.5 | |
| Accrued expenses and accounts receivable allowances | 17.7 | | | 8.2 | |
| Loss carryforwards | 44.5 | | | 6.1 | |
| Inventories | 17.1 | | | 7.8 | |
| Stock-based compensation | 6.2 | | | 5.6 | |
| Operating lease liabilities | 18.1 | | | 7.5 | |
| Convertible bond | 27.1 | | | 4.9 | |
| Research and development costs | 58.7 | | | 51.5 | |
| Credit carryforwards | 18.5 | | | 6.0 | |
| Acquisition costs | — | | | 5.4 | |
| Interest expense carryforwards | 10.9 | | | 3.5 | |
| Derivative instruments | 11.7 | | | — | |
| Other | 9.2 | | | 0.8 | |
| Total deferred tax assets | $ | 246.6 | | | $ | 112.8 | |
| Valuation allowance | (39.2) | | | (5.3) | |
| Deferred tax assets, net of valuation allowance | $ | 207.4 | | | $ | 107.5 | |
| Deferred tax liabilities attributable to: | | | |
| Property, plant and equipment | 68.0 | | | 16.7 | |
| Goodwill and intangibles | 468.3 | | | 61.5 | |
| Right to use lease assets | 17.2 | | | 7.2 | |
| Derivative instruments | — | | | 0.7 | |
| Other | — | | | 1.0 | |
| Total deferred tax liabilities | $ | 553.5 | | | $ | 87.1 | |
| Net deferred tax liabilities | $ | (346.1) | | | $ | 20.4 | |
Included in deferred tax assets are tax benefits related to operating loss carryforwards totaling $44.5 million, comprised of US Federal ($9.6 million), US state ($8.0 million), and non-US ($26.9 million) loss carryforwards. Of this amount $24.9 million are available to offset future tax liabilities indefinitely, and $19.6 million, if unused, are set to expire at various dates starting in 2026 through 2045.
As of December 31, 2025 tax credit carryforwards totaled $18.5 million, which primarily include US federal credits of $15.2 million and U.S. state credits of $2.7 million which, if unused, are set to expire at various dates starting in 2032 through 2045.
Of the tax effected loss and credit carryforwards, approximately $31.5 million are subject to a full valuation allowance, as management has concluded that based on the available evidence, it is more likely than not that the deferred tax assets will not be fully utilized. These valuation allowances are primarily associated with operations in the United States, Iceland, Germany, Belgium, and Singapore.
The Company considers certain unremitted earnings of foreign subsidiaries indefinitely reinvested. The amount of unrecognized deferred tax liabilities associated with these earnings is approximately $2 million.
Income Tax Contingencies
As of December 31, 2025, the Company had unrecognized tax benefits of $16.1 million that, if recognized, would impact the Company’s effective tax rate. In 2025, the Company recorded unrecognized tax benefits related to the Marel acquisition as part of the purchase accounting, which did not impact the current year effective tax rate.
Activity related to the Company’s unrecognized tax benefits for the years ended December 31 are shown below:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Balance, beginning of period | $ | — | | | $ | 0.3 | | | $ | — | |
| Settlements and effective settlements with tax authorities | — | | | (0.3) | | | — | |
| Changes in balance related to tax positions taken during current period | 1.7 | | | — | | | 0.3 | |
| Changes in balance related to tax positions taken during prior periods | 14.4 | | | — | | | — | |
| Balance, end of period | $ | 16.1 | | | $ | — | | | $ | 0.3 | |
As of December 31, 2025, we had accrued interest and penalties, net of federal income tax benefit, related to income tax contingencies of $0.6 million through income tax expense.
Cash Taxes Paid
The Company adopted ASU 2023-09 on a prospective basis for the year ended December 31, 2025. The following table presents required disclosures of income taxes paid, net of refunds received, for the year ended December 31, 2025:
| | | | | |
| (In millions) | |
| U.S. federal | $ | (1.1) | |
| U.S. state and local | 2.4 | |
| Non-U.S. | |
| Brazil | 7.8 | |
| Netherlands | 25.9 | |
| Sweden | 15.0 | |
| Other foreign jurisdictions | 18.7 | |
| Total cash paid for taxes | $ | 68.7 | |
Income taxes paid for the years ended December 31, 2024 and 2023 were:
| | | | | | | | | | | |
| (In millions) | 2024 | | 2023 |
| Supplemental cash flow information for continuing operations: | | | |
| Income taxes paid | $ | 33.2 | | | $ | 47.1 | |
| Income taxes paid on gain from sale of AeroTech | — | | | 133.2 | |
NOTE 10. PENSION AND POST-RETIREMENT AND OTHER BENEFIT PLANS
The Company sponsors nonqualified defined benefit pension plans that cover some of its U.S. employees. The plan provides defined benefits based on years of service and final average salary. The Company also sponsors a noncontributory plan that provides post-retirement life insurance benefits (“OPEB”) to some of its U.S. employees. Non-U.S. based employees are eligible to participate in either Company-sponsored or government-sponsored benefit plans to which the Company contributes. The Company also sponsors separate defined contribution plans that cover substantially all of its U.S. employees and some non-U.S. employees.
Termination of U.S. qualified defined benefit pension plan
During 2024, the Company obtained approval from its Board of Directors to settle all outstanding obligations of the U.S. qualified defined benefit pension plan (the “Plan”), through a combination of voluntary lump sum payments and the purchase of an annuity contract. During the fourth quarter of 2024, the Company recognized a settlement charge of $23.3 million from its pre-tax accumulated loss related to the Plan as a non-cash, pre-tax pension expense. On February 4, 2025, the Company completed the termination of the Plan via the purchase of an annuity contract for $178.5 million, funded entirely by the Plan assets. No additional cash contribution was required to settle the Company’s outstanding obligations and terminate the Plan.
The final settlement of the Plan triggered a remeasurement of the related plan benefit obligation and assets as of February 4, 2025. The net effect of the Plan remeasurement was an increase in the net funded status of the Plan of $3.4 million primarily due to an increase in the discount rate used to value to the pension liability and assets. Upon the termination, the Company recognized a pre-tax settlement charge of $146.9 million in Pension expense, other than service cost to recognize the remaining pre-tax accumulated other comprehensive loss related to the Plan.
The funded status of the Company’s pension plans, together with the associated balances recognized in its consolidated financial statements as of December 31, 2025 and 2024, were as follows:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Projected benefit obligation at January 1 | $ | 223.3 | | | $ | 274.1 | |
| Service cost | 1.3 | | | 1.2 | |
| Interest cost | 1.2 | | | 12.2 | |
| Actuarial (gain) loss | (1.1) | | | (13.5) | |
Plan participants’ contributions | 0.2 | | | 0.2 | |
| Benefits paid | (7.2) | | | (48.2) | |
| Settlements | (178.5) | | | — | |
| Plan amendments | 1.1 | | | — | |
| Currency translation adjustments | 5.6 | | | (2.7) | |
| Projected benefit obligation at December 31 | $ | 45.9 | | | $ | 223.3 | |
| Fair value of plan assets at January 1 | $ | 201.1 | | | $ | 249.9 | |
| Company contributions | 2.4 | | | 3.0 | |
| Actual return on plan assets | (0.5) | | | (2.8) | |
Plan participants’ contributions | 0.2 | | | 0.2 | |
| Benefits paid | (7.6) | | | (48.2) | |
| Assets contributed to 401(k) savings plan | (0.9) | | | — | |
| Plan amendments | 0.7 | | | — | |
| Settlements | (178.5) | | | — | |
| Currency translation adjustments | 2.1 | | | (1.0) | |
| Fair value of plan assets at December 31 | $ | 19.0 | | | $ | 201.1 | |
| Funded status of the plans (liability) at December 31 | $ | (26.9) | | | $ | (22.2) | |
| Amounts recognized in the Consolidated Balance Sheets at December 31 | | | |
| Other current liabilities | (4.7) | | | (4.3) | |
| Accrued pension and other post-retirement benefits, less current portion | (22.2) | | | (17.8) | |
| Net amount recognized | $ | (26.9) | | | $ | (22.1) | |
The liability associated with the OPEB plan included in the consolidated financial statements was $1.8 million and $1.7 million as of December 31, 2025 and 2024, respectively.
Amounts recognized in accumulated other comprehensive loss at December 31, 2025 and 2024 were, $7.8 million and $153.5 million, respectively for pensions, and $(0.4) million and $(0.7) million for the OPEB plan, respectively. These amounts were primarily unrecognized actuarial gains and losses.
The accumulated benefit obligation for all pension plans was $39.9 million and $218.3 million at December 31, 2025 and 2024, respectively. All pension plans had accumulated benefit obligations in excess of plan assets as of December 31, 2025. For the year ended December 31, 2025, accumulated benefit obligation for the pension plans decreased primarily due to the termination of the U.S. qualified defined benefit pension plan.
Pension costs (income) for the years ended December 31, were as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Service cost | $ | 1.3 | | | $ | 1.2 | | | $ | 1.1 | |
| Interest cost | 2.3 | | | 12.2 | | | 12.8 | |
| Expected return on plan assets | (1.2) | | | (13.6) | | | (17.1) | |
| Amortization of net actuarial loss | 0.5 | | | 5.4 | | | 5.0 | |
| Settlement charge recognized | 146.9 | | | 23.3 | | | — | |
| Total costs | $ | 149.8 | | | $ | 28.5 | | | $ | 1.8 | |
OPEB plan costs were not material for the years ended December 31, 2025, 2024, and 2023.
Pre-tax changes in projected benefit obligations and plan assets recognized in other comprehensive loss during 2025 for the OPEB plan were not material and for the pension plans were as follows:
| | | | | |
| (In millions) | Pensions |
| Actuarial gain | $ | 3.4 | |
| Amortization of net actuarial loss | (146.4) | |
| Net income recognized in other comprehensive income | $ | (143.0) | |
| Total recognized in net periodic benefit cost and other comprehensive income | $ | 6.8 | |
The Company uses a corridor approach to recognize actuarial gains and losses that result from changes in actuarial assumptions. The corridor approach defers all actuarial gains and losses resulting from changes in assumptions in other accumulated other comprehensive income (loss), such as those related to changes in the discount rate and differences between actual and expected returns on plan assets. These unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the higher of the market-related value of the assets or the projected benefit obligation for each respective plan. The amortization is on a straight-line basis over the life expectancy of the plan’s participants for the frozen plans and the expected remaining service periods for the other plans.
Beginning in 2010, the U.S. defined benefit plans were frozen to new entrants and future benefit accruals for non-union participants were discontinued.
The following weighted-average assumptions were used to determine the benefit obligations for the pension plans:
| | | | | | | | | | | | | | | | | |
| 2025 | | 2024 | | 2023 |
| Discount rate | 3.52% | | 5.13% | | 4.74% |
| Rate of compensation increase | 2.76% | | 2.72% | | 2.56% |
The following weighted-average assumptions were used to determine net periodic benefit cost for the pension plans:
| | | | | | | | | | | | | | | | | |
| 2025 | | 2024 | | 2023 |
| Discount rate | 3.36% | | 4.71% | | 5.00% |
| Rate of compensation increase | 2.76% | | 2.72% | | 2.56% |
| Expected rate of return on plan assets | 3.80% | | 4.88% | | 6.08% |
The estimate of the expected rate of return on plan assets is based primarily on the historical performance of plan assets, asset allocation, current market conditions and long-term growth expectations.
Plan assets
The Company’s pension investment strategy balances the requirements to generate returns using higher-returning assets, such as equity securities, with the need to control risk in the pension plan with less volatile assets, such as fixed-income securities. Risks include, among others, the likelihood of the pension plans being underfunded, thereby increasing their dependence on Company contributions. The assets are managed by professional investment firms and performance is evaluated against specific benchmarks.
Target asset allocations and actual allocations as of December 31, 2025 and 2024 were as follows:
| | | | | | | | | | | | | | | | | |
| Target | | 2025 | | 2024 |
| Fixed income | 0% | | —% | | 81% |
| Real estate and other | 100% | | 100% | | 11% |
| Cash | 0% | | —% | | 8% |
| | | 100% | | 100% |
Actual pension plans’ asset holdings by category and level within the fair value hierarchy are presented in the following table:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, 2025 | | As of December 31, 2024 |
| (In millions) | Total | | Level 1 | | Level 2 | | Total | | Level 1 | | Level 2 |
| Cash and cash equivalents | $ | — | | | $ | — | | | $ | — | | | $ | 12.3 | | | $ | 12.3 | | | $ | — | |
| Fixed income securities: | | | | | | | | | | | |
Government securities(1) | — | | | — | | | — | | | 77.0 | | | — | | | 77.0 | |
Corporate bonds(2) | — | | | — | | | — | | | 45.7 | | | — | | | 45.7 | |
Other investments(3) | 19.0 | | | — | | | 19.0 | | | 15.6 | | | — | | | 15.6 | |
| Total assets at fair value | $ | 19.0 | | | $ | — | | | $ | 19.0 | | | $ | 150.6 | | | $ | 12.3 | | | $ | 138.3 | |
Investments valued using NAV as a practical expedient(4) | — | | | | | | | 50.1 | | | | | |
| Total assets | $ | 19.0 | | | | | | | $ | 200.7 | | | | | |
(1)Includes U.S. government securities and funds that invest primarily in U.S. government bonds, including treasury inflation protected securities.
(2)Includes funds that invest in investment grade bonds, high yield bonds and mortgage-backed fixed income securities.
(3)Includes funds that invest primarily in commodities and investments in insurance contracts held by the Company’s foreign pension plans.
(4)The Company elected the practical expedient to characterize certain new investments which are measured at net asset values (“NAV”) that have not been classified in the fair value hierarchy.
The fair value of assets classified as Level 1 is based on unadjusted quoted prices in active markets for identical assets. The fair value of assets classified as Level 2 is based on quoted prices for similar assets or based on valuations made using inputs that are either directly or indirectly observable as of the reporting date. Such inputs include net asset values reported at a minimum on a monthly basis by investment funds or contract values provided by the issuing insurance company. The Company is able to sell any of its investment funds with notice of no more than 30 days. For more information on the fair value hierarchy, see Note 16. Fair Value of Financial Instruments.
Contributions
The Company expects to contribute $2.9 million to its pension and other post-retirement benefit plans in 2026. The pension contributions will primarily be made to the non-U.S. pension plans. All of the contributions are expected to be in the form of cash.
Estimated future benefit payments
The following table summarizes expected benefit payments from various pension benefit plans through 2035. Actual benefit payments may differ from expected benefit payments.
| | | | | |
| (In millions) | Pensions |
| 2026 | $ | 5.3 | |
| 2027 | 2.0 | |
| 2028 | 2.2 | |
| 2029 | 1.9 | |
| 2030 | 2.1 | |
| 2031-2035 | 17.5 | |
Savings Plans
U.S. and some international employees participate in defined contribution savings plans that the Company sponsors. These plans generally provide company matching contributions on participants’ voluntary contributions and/or company non-elective contributions. Additionally, certain highly compensated employees participate in a non-qualified deferred compensation plan, which also allows for company matching contributions and company non-elective contributions on compensation in excess of the Internal Revenue Code Section 401(a) (17) limit. The expense for matching contributions was $20.1 million, $15.3 million, and $13.6 million in 2025, 2024 and 2023, respectively.
NOTE 11. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Accumulated other comprehensive income or loss (“AOCI”) represents the cumulative balance of other comprehensive income, net of tax, as of the Balance Sheet date. For the Company, AOCI is composed of adjustments related to pension and other post-retirement benefits plans, derivatives designated as hedges, and foreign currency translation adjustments. Changes in the AOCI balances for the years ended December 31, 2025 and 2024 by component are shown in the following table:
| | | | | | | | | | | | | | | | | | | | | | | |
| (In millions) | Pension and Other Post-retirement Benefits(1) | | Derivatives Designated as Hedges(1) | | Foreign Currency Translation(1) | | Total(1) |
| Balance as of January 1, 2024 | $ | (132.7) | | | $ | 9.2 | | | $ | (72.3) | | | $ | (195.8) | |
| Other comprehensive income (loss) before reclassification | (2.2) | | | 1.2 | | | (40.8) | | | (41.8) | |
| Amounts reclassified from accumulated other comprehensive income | 21.4 | | | (8.3) | | | — | | | 13.1 | |
| Balance as of December 31, 2024 | $ | (113.5) | | | $ | 2.1 | | | $ | (113.1) | | | $ | (224.5) | |
| Other comprehensive income (loss) before reclassification | (1.8) | | | (10.7) | | | 426.5 | | | 414.0 | |
| Amounts reclassified from accumulated other comprehensive income | 108.8 | | | (9.7) | | | (7.4) | | | 91.7 | |
| Balance as of December 31, 2025 | $ | (6.5) | | | $ | (18.3) | | | $ | 306.0 | | | $ | 281.2 | |
(1) All amounts are net of income taxes.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the year ended December 31, 2025 were $146.4 million of charges to pension expense, other than service cost, net of $37.6 million in income tax benefit. Reclassification adjustments for derivatives designated as hedges for the year ended December 31, 2025 were $2.4 million of benefit in interest expense, net of $0.6 million income tax provision and $10.6 million of benefit in other income, net of $2.7 million income tax provision. Reclassification adjustments for foreign currency translation related to net investment hedges for the year ended December 31, 2025 were $9.9 million of benefit in interest expense, net of $2.5 million income tax provision.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the year ended December 31, 2024 were $28.7 million of charges to pension expense, other than service cost, net of $7.3 million in income tax benefit. Reclassification adjustments for derivatives designated as hedges for the year ended December 31, 2024 were $11.1 million of benefit in interest expense, net of $2.8 million income tax provision.
NOTE 12. STOCK-BASED COMPENSATION
The Company recorded stock-based compensation expense and related income tax effects for the years ended December 31, as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Stock-based compensation expense | $ | 23.2 | | | $ | 14.7 | | | $ | 11.4 | |
| Tax benefit recorded in consolidated statements of income | $ | 8.1 | | | $ | 3.2 | | | $ | 2.9 | |
As of December 31, 2025, there was $27.5 million of unrecognized stock-based compensation expense for outstanding awards expected to be recognized over a weighted average period of 1.9 years.
Incentive Compensation Plan
The Company sponsors a stock-based compensation plan (the “Incentive Compensation Plan”) that provides certain incentives and awards to its officers, employees, directors and consultants. The Incentive Compensation Plan allows the Compensation and Human Resources Committee (the “Committee”) of the Board of Directors to make various types of awards to eligible individuals. Awards that may be issued include common stock, stock options, stock appreciation rights, restricted stock and stock units.
Restricted stock unit awards specify any applicable performance goals, the time and rate of vesting and such other provisions as determined by the Committee. Restricted stock units generally vest after 3 years of service, but may also vest upon a change of control as defined in the Incentive Compensation Plan. The 2017 Incentive Compensation Plan was approved by stockholders in May 2017. The 2017 Incentive Compensation Plan replaced the prior incentive compensation plan (the “2008 Incentive Compensation Plan”). The aggregate number of shares of common stock that are authorized for issuance under the 2017 Incentive Compensation Plan is (i) 1,000,000 shares, plus (ii) the number of shares of common stock that remained available for issuance under the 2008 Incentive Compensation Plan on the effective date of the 2017 Incentive Compensation Plan, plus (iii) the number of shares of common stock that were subject to outstanding awards under the 2008 Incentive Compensation Plan on the effective date of the 2017 Incentive Compensation Plan that are canceled, forfeited, returned or withheld without the issuance of shares thereunder.
Impact of Retirement on Outstanding Awards
In the event of an executive officer’s retirement from the Company upon or after attaining age 62 and a specified number of years of service, any nonvested awards remain outstanding after retirement and vest on the originally scheduled vesting date. This permits flexibility in retirement planning, permits the Company to provide an incentive for the vesting period and does not penalize employees who receive awards as incentive compensation when they retire.
Restricted Stock Units
A summary of the nonvested restricted stock units as of December 31, 2025 and changes during the year is presented below:
| | | | | | | | | | | |
| Shares | | Weighted-Average Grant-Date Fair Value |
| Nonvested at December 31, 2024 | 554,575 | | | $ | 79.19 | |
| Granted | 275,421 | | | $ | 130.20 | |
| Vested | (221,721) | | | $ | 88.47 | |
| Forfeited | (14,188) | | | $ | 122.73 | |
| Nonvested at December 31, 2025 | 594,087 | | | $ | 98.83 | |
The Company grants time-based and performance-based restricted stock units with a vesting period of one to three years, but vesting periods can vary based on the discretion of the Committee. The fair value of these awards is determined using the market value of common stock on the grant date. Compensation cost is recognized over the lesser of the stated vesting period or the period until the employee meets the retirement eligible age and service requirements under the plan.
The number of shares to be issued for performance-based restricted stock units awards made in 2025, 2024, and 2023, is dependent upon performance over the three year period ending December 31st of the respective term, with respect to cumulative diluted earnings per share from continuing operations and average operating return on invested capital (ROIC). The payout for 2025 grants of performance-based units is also dependent and may increase or decrease by 20% if the Company’s three year total shareholder return is within the top quartile or bottom quartile, respectively, of the comparator group of the Standard & Poor’s 1500 Industrial Machinery index. ROIC is defined as net income plus after tax net interest expense divided by average invested capital, which is an average of total shareholders equity plus debt plus future pension expenses held in AOCI less cash and cash equivalents. Based on results achieved in 2025, 2024, and 2023, and the forecasted amounts over the remainder of the performance period, the Company expects to issue a total of 97,830, 78,720, and 69,161, shares at the vesting dates in February 2028, February 2027, and February 2026, respectively. Compensation cost has been measured in 2025 based on these expectations.
The following summarizes values for restricted stock activity in each of the years in the three year period ended December 31:
| | | | | | | | | | | | | | | | | |
| 2025 | | 2024 | | 2023 |
| Weighted-average grant-date fair value of restricted stock units granted | $ | 130.20 | | | $ | 101.56 | | | $ | 109.28 | |
| Fair value of restricted stock vested (in millions) | $ | 26.9 | | | $ | 8.4 | | | $ | 5.6 | |
NOTE 13. STOCKHOLDERS’ EQUITY
The following is a summary of capital stock activity (in shares) for the year ended December 31, 2025:
| | | | | | | | | | | |
| Common Stock Outstanding | | Common Stock Held in Treasury |
| December 31, 2024 | 31,843,794 | | | 17,886 | |
| Common stock issued | 19,979,633 | | | (17,886) | |
| Stock awards issued | 150,928 | | | — | |
| December 31, 2025 | 51,974,355 | | | — | |
On January 2, 2025, the Company issued 19,979,633 shares of its common stock to Marel shareholders for the Marel Transaction and Squeeze out, representing approximately 38 percent of its ownership in the combined company upon completion of the issuance.
NOTE 14. REVENUE RECOGNITION
Transaction price allocated to the remaining performance obligations
The Company has estimated that $1,372.0 million in revenue is expected to be recognized in the future periods related to remaining performance obligations from the Company’s contracts with customers outstanding as of December 31, 2025. The Company expects to complete these obligations and recognize revenue in the range of 85% to 95% in 2026 and the remainder after 2026.
Disaggregation of Revenue
In the following table, revenue is disaggregated by type of good or service and primary geographical market for each reportable segment. The table also includes a reconciliation of the disaggregated revenue to total revenue.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, |
| 2025 (1) | | 2024 (1) | | 2023 (1) |
| (In millions) | Protein Solutions | | Prepared Food and Beverage Solutions | | Protein Solutions | | Prepared Food and Beverage Solutions | | Protein Solutions | | Prepared Food and Beverage Solutions |
| Type of Good or Service | | | | | | | | | | | |
Recurring (2) | $ | 900.3 | | | $ | 1,012.2 | | | $ | 108.2 | | | $ | 734.6 | | | $ | 117.0 | | | $ | 728.6 | |
Non-recurring (2) | 815.9 | | | 1,069.8 | | | 60.5 | | | 812.7 | | | 70.8 | | | 748.0 | |
| Total | $ | 1,716.2 | | | $ | 2,082.0 | | | $ | 168.7 | | | $ | 1,547.3 | | | $ | 187.8 | | | $ | 1,476.6 | |
| | | | | | | | | | | |
Geographical Region (3) | | | | | | | | | | | |
| U.S. and Canada | $ | 544.4 | | | $ | 983.1 | | | $ | 151.5 | | | $ | 819.0 | | | $ | 170.7 | | | $ | 807.8 | |
| Europe, Middle East and Africa | 827.5 | | | 694.6 | | | 5.8 | | | 459.3 | | | 2.7 | | | 418.7 | |
| Asia Pacific | 147.8 | | | 209.0 | | | 8.1 | | | 145.6 | | | 6.5 | | | 136.8 | |
| Latin America | 196.5 | | | 195.3 | | | 3.3 | | | 123.4 | | | 7.9 | | | 113.3 | |
| Total | $ | 1,716.2 | | | $ | 2,082.0 | | | $ | 168.7 | | | $ | 1,547.3 | | | $ | 187.8 | | | $ | 1,476.6 | |
(1) Effective in the fourth quarter of 2025, segment revenues for the years ended December 31, 2025, 2024 and 2023 were recast to reflect the Company’s realignment of its reportable segments.
(2) Recurring revenue includes revenue from aftermarket parts and services, re-build services on customer owned equipment, operating leases of equipment, and subscription-based software applications. Non-recurring revenue includes new equipment and installation and the sale of software licenses.
(3) Geographical region represents the region in which the end customer resides.
Contract balances
The timing of revenue recognition, billings and cash collections results in trade receivables, contract assets, and advance and progress payments (contract liabilities). Contract assets exist when revenue recognition occurs prior to billings. Contract assets are transferred to trade receivables when the right to payment becomes unconditional (i.e., when receipt of the amount is dependent only on the passage of time). Conversely, the Company often receives payments from its customers before revenue is recognized, resulting in contract liabilities. These assets and liabilities are reported on the Consolidated Balance Sheets as contract assets and within advance and progress payments, respectively, on a contract-by-contract net basis at the end of each reporting period.
Contract asset and liability balances for the period were as follows:
| | | | | | | | | | | | | | | | | | | |
| Balances as of | | |
| (In millions) | December 31, 2025 | | December 31, 2024 | | December 31, 2023 | | |
| Contract Assets | $ | 118.5 | | | $ | 95.4 | | | $ | 74.5 | | | |
| Contract Liabilities | 498.5 | | | 178.0 | | | 156.5 | | | |
The revenue recognized during the year ended December 31, 2025, 2024 and 2023 that was included in contract liabilities at the beginning of the year amounted to $173.7 million, $141.8 million, and $150.0 million respectively. The Company assumed contract liabilities from acquisitions in the amount of $263.1 million in 2025. The remainder of the change from December 31, 2025, December 31, 2024 and December 31, 2023 is driven by the timing of advance and milestone payments received from customers, customer returns, and fulfillment of performance obligations. There were no significant changes in the contract balances other than those described above.
NOTE 15. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share (“EPS”) from net income for the respective periods and basic and diluted shares outstanding:
| | | | | | | | | | | | | | | | | |
| (In millions, except per share data) | 2025 | | 2024 | | 2023 |
| Basic earnings per share: | | | | | |
| (Loss) income from continuing operations | $ | (49.7) | | | $ | 84.6 | | | $ | 129.3 | |
| (Loss) income from discontinued operations, net of taxes | (0.8) | | | 0.8 | | | 453.3 | |
| Net (loss) income | $ | (50.5) | | | $ | 85.4 | | | $ | 582.6 | |
| Weighted average number of shares outstanding | 52.0 | | | 32.0 | | | 32.0 | |
| Basic (loss) earnings per share from: | | | | | |
| Continuing operations | $ | (0.96) | | | $ | 2.65 | | | $ | 4.04 | |
| Discontinued operations | (0.02) | | | 0.02 | | | 14.17 | |
| Net (loss) income | $ | (0.98) | | | $ | 2.67 | | | $ | 18.21 | |
| Diluted (loss) earnings per share: | | | | | |
| Loss (income) from continuing operations | $ | (49.7) | | | $ | 84.6 | | | $ | 129.3 | |
| Loss (income) from discontinued operations, net of tax | (0.8) | | | 0.8 | | | 453.3 | |
| Net (loss) income | $ | (50.5) | | | $ | 85.4 | | | $ | 582.6 | |
| Weighted average number of shares outstanding | 52.0 | | | 32.0 | | | 32.0 | |
| Effect of dilutive securities: | | | | | |
Restricted stock(1) | — | | | 0.2 | | | 0.1 | |
| Total shares and dilutive securities | 52.0 | | | 32.2 | | | 32.1 | |
| Diluted earnings per share from: | | | | | |
| Continuing operations | $ | (0.96) | | | $ | 2.63 | | | $ | 4.02 | |
| Discontinued operations | (0.02) | | | 0.02 | | | 14.11 | |
| Net (loss) income | $ | (0.98) | | | $ | 2.65 | | | $ | 18.13 | |
| | | | | |
Restricted stock shares with anti-dilutive effect excluded from the computation of diluted earnings per share(1) | 0.2 | | | — | | | — | |
NOTE 16. DERIVATIVE FINANCIAL INSTRUMENTS AND CREDIT RISK
Derivative financial instruments
All derivatives are recorded as assets or liabilities in the Consolidated Balance Sheets at their respective fair values. For derivatives designated as cash flow hedges, the unrealized gain or loss related to the derivatives is recorded in Other comprehensive income (loss) until the hedged transaction affects earnings. The Company assesses at inception of the hedge whether the derivative in the hedging transaction will be highly effective in offsetting changes in cash flows of the hedged item. Changes in the fair value of derivatives that do not meet the criteria for designation as a hedge are recognized in earnings.
Foreign Exchange: The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates. The Company’s major foreign currency exposures involve the markets in Western Europe, South America and Asia. Some sales and purchase contracts contain embedded derivatives due to the nature of doing business in certain jurisdictions, which the Company takes into consideration as part of its risk management policy. The purpose of foreign currency hedging activities is to manage the economic impact of exchange rate volatility associated with anticipated foreign currency purchases and sales made in the normal course of business. The Company primarily utilizes forward foreign exchange contracts with maturities of less than one year in managing this foreign exchange rate risk. The Company has not designated these forward foreign exchange contracts, which had a notional value at December 31, 2025 of $443.6 million, as hedges and therefore does not apply hedge accounting.
The fair values of our foreign currency assets are recorded within other current assets and other assets, and the fair values of foreign currency derivative liabilities are recorded within other current liabilities and other liabilities. The following table presents the fair value of foreign currency derivatives and embedded derivatives included within the Consolidated Balance Sheets:
| | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, 2025 | | As of December 31, 2024 |
| (In millions) | Derivative Assets | | Derivative Liabilities | | Derivative Assets | | Derivative Liabilities |
| Total | $ | 3.7 | | | $ | 3.4 | | | $ | 3.8 | | | $ | 44.4 | |
A master netting arrangement allows counterparties to net settle amounts owed to each other as a result of separate offsetting derivative transactions. The Company enters into master netting arrangements with its counterparties when possible to mitigate credit risk in derivative transactions by permitting it to net settle for transactions with the same counterparty. However, the Company does not net settle with such counterparties. As a result, the Company presents derivatives at their gross fair values in the Consolidated Balance Sheets.
As of December 31, 2025 and 2024, information related to these offsetting arrangements was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (In millions) | As of December 31, 2025 |
| Offsetting of Assets | | | | | | | | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amount Presented in the Consolidated Balance Sheets | | Amount Subject to Master Netting Agreement | | Net Amount |
| Derivatives | $ | 3.8 | | | $ | — | | | $ | 3.8 | | | $ | (1.9) | | | $ | 1.9 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Offsetting of Liabilities | As of December 31, 2025 |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amount Presented in the Consolidated Balance Sheets | | Amount Subject to Master Netting Agreement | | Net Amount |
| Derivatives | $ | 141.7 | | | $ | — | | | $ | 141.7 | | | $ | (1.9) | | | $ | 139.8 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (In millions) | As of December 31, 2024 |
| Offsetting of Assets | | | | | | | | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amount Presented in the Consolidated Balance Sheets | | Amount Subject to Master Netting Agreement | | Net Amount |
| Derivatives | $ | 6.3 | | | $ | — | | | $ | 6.3 | | | $ | (1.6) | | | $ | 4.7 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Offsetting of Liabilities | As of December 31, 2024 |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amount Presented in the Consolidated Balance Sheets | | Amount Subject to Master Netting Agreement | | Net Amount |
| Derivatives | $ | 44.3 | | | $ | — | | | $ | 44.3 | | | $ | (1.6) | | | $ | 42.7 | |
The following table presents the location and amount of the loss on foreign currency derivatives and on the remeasurement of assets and liabilities denominated in foreign currencies, as well as the net impact recognized in the Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Derivatives Not Designated as Hedging Instruments | | Location of Gain (Loss) Recognized in Income | | Amount of Gain (Loss) Recognized in Income |
| (In millions) | | | | 2025 | | 2024 | | 2023 |
| Foreign exchange contracts | | Revenue | | $ | 8.5 | | | $ | (6.6) | | | $ | 2.0 | |
| Foreign exchange contracts | | Cost of sales | | (4.5) | | | 4.1 | | | (0.2) | |
| Foreign exchange contracts | | Selling, general and administrative expense | | (0.6) | | | (43.7) | | | 0.4 | |
| Total | | | | $ | 3.4 | | | $ | (46.2) | | | $ | 2.2 | |
| Remeasurement of assets and liabilities in foreign currencies | | | | (10.2) | | | 1.2 | | | (1.6) | |
| Net gain (loss) | | | | $ | (6.8) | | | $ | (45.0) | | | $ | 0.6 | |
The following table presents the location and amount of the gain (loss) on derivatives that have been designated as hedging instruments in the Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives Designated as Hedging Instruments | | Location of Gain (Loss) Recognized in Income on Derivatives | | Amount of Gain (Loss) Recognized in Income |
| | | | 2025 | | 2024 | | 2023 |
| (In millions) | | | | | | | | |
Foreign currency derivatives | | Other income | | $ | 10.6 | | | $ | — | | | $ | — | |
Foreign currency derivatives | | Interest expense | | 9.9 | | | — | | | 1.5 | |
Interest rate swaps | | Interest expense | | 2.4 | | | 11.1 | | | 10.8 | |
| Total gain (loss) | | | | $ | 22.9 | | | $ | 11.1 | | | $ | 12.3 | |
Net Investment:The Company uses cross currency swaps to hedge portions of its net investments denominated in Euro against the effect of adverse foreign exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The gains or losses on these derivative instruments are included in the foreign currency translation component of other comprehensive income until the net investment is sold, diluted, or liquidated. The Company elected to use the spot method to assess the effectiveness for these derivatives that are designated as net investment hedges for accounting purposes. Coupons received for the cross currency swaps are excluded from the net investment hedge effectiveness assessment and are recorded in Interest expense in the Consolidated Statements of Income. Cash flows related to coupons received on the swaps are included in operating activities in the Consolidated Statements of Cash Flows and the final exchange on the swaps will be reported in financing activities.
In July 2018, the Company entered into a series of cross currency swap agreements that synthetically swap $116.4 million of U.S. dollar denominated fixed rate debt to Euro denominated fixed rate debt. The agreements were designated as net investment hedges for accounting purposes. The agreements matured in July 2023 resulting in cash proceeds and a gain of $5.8 million that is recognized in Accumulated other comprehensive loss on the Balance Sheets.
During the second quarter of 2025, the Company entered into a series of cross currency swap agreements that synthetically swap U.S. dollar denominated fixed rate debt to Euro denominated fixed rate debt with a notional amount of $578 million. These cross currency swaps were designated as net investment hedges with maturity dates in June 2030.
During the third quarter of 2025, the Company entered into a series of cross currency swap agreements that synthetically swap U.S. dollar denominated fixed rate debt to Euro denominated fixed rate debt with a total notional amount of $1.6 billion. These cross currency swaps were designated as net investment hedges, and $986 million of the swaps mature in June 2029 and $581 million mature in June 2031, respectively.
At December 31, 2025, the fair value of these derivatives designated as net investment hedges were recorded in the Consolidated Balance Sheets as Other liabilities of $23.3 million and as Accumulated other comprehensive income, net of tax, of $17.4 million
Fair Value: On January 3, 2025, the Company entered into five cross-currency swaps expiring in January 2032 related to the portion of the U.S. dollar denominated Term Loan B drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $694.8 million and synthetically swap interest rates from SOFR to EURIBOR and hedge the impact of variability in exchange rates on the U.S. dollar dominated debt and related interest payments, excluding the credit spread, by our euro-functional entity.
The Company has designated these swaps as fair value hedges and changes in the fair value of these swaps are recognized in earnings in the period realized. The gains and losses related to the change in the fair value of the hedged components of the swaps are included in other income and substantially offset the change in the fair value of the hedged portion of the underlying debt that is attributable to the change in euro to U.S. dollar exchange rates. Changes in fair value of the swaps related to excluded components of the derivative instruments are recognized in accumulated other comprehensive income and recognized into earnings systematically over the life of the hedged instrument.
At December 31, 2025, the fair value of these derivatives designated as fair value hedges was recorded in the Consolidated Balance Sheets as Other liabilities of $116.6 million and as Accumulated other comprehensive income, net of tax, of $19.5 million.
Interest Rates: In March 2020, the Company executed four interest rate swaps with a combined notional amount of $200 million and in May 2020 the Company executed one interest rate swap with a notional amount of $50 million. These interest rate swaps fixed the interest rate applicable to certain of the Company’s variable-rate debt and swapped one-month SOFR rates for fixed rates. The Company designated these swaps as cash flow hedges and all changes in fair value of the swaps were recognized in accumulated other comprehensive income. The interest rate swaps expired during the second quarter of 2025.
At December 31, 2024, the fair value of these derivatives designated as cash flow hedges was recorded in the Consolidated Balance Sheet as other assets of $3.0 million and as accumulated other comprehensive income, net of tax, of $2.1 million.
Refer to Note 16. Fair Value of Financial Instruments, for a description of how the values of the above financial instruments are determined.
Credit risk
By their nature, financial instruments involve risk including credit risk for non-performance by counterparties. Financial instruments that potentially subject the Company to credit risk primarily consist of trade receivables and derivative contracts. The Company manages the credit risk on financial instruments by transacting only with financially secure counterparties, requiring credit approvals and establishing credit limits, and monitoring counterparties’ financial condition. The Company’s maximum exposure to credit loss in the event of non-performance by the counterparty, for all receivables and derivative contracts as of December 31, 2025, is limited to the amount outstanding on the financial instrument. Allowances for losses are established based on collectability assessments. Refer to Note 1. Summary of Significant Accounting Policies for a description of how allowance for credit loss is determined on financial assets measured at amortized cost, which includes Trade receivables, Contract assets, and non-current receivables.
NOTE 17. FAIR VALUE OF FINANCIAL INSTRUMENTS
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
•Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities that the Company can assess at the measurement date.
•Level 2: Observable inputs other than those included in Level 1 that are observable for the asset or liability, either directly or indirectly. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
•Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
Financial assets and financial liabilities measured at fair value on a recurring basis are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, 2025 | | As of December 31, 2024 |
| (In millions) | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 |
| Assets: | | | | | | | | | | | | | | | |
| Investments | $ | 35.9 | | | $ | 35.9 | | | $ | — | | | $ | — | | | $ | 13.2 | | | $ | 13.2 | | | $ | — | | | $ | — | |
| Derivatives | 3.7 | | | — | | | 3.7 | | | | | 6.8 | | | — | | | 6.8 | | | |
| Total assets | $ | 39.6 | | | $ | 35.9 | | | $ | 3.7 | | | $ | — | | | $ | 20.0 | | | $ | 13.2 | | | $ | 6.8 | | | $ | — | |
| | | | | | | | | | | | | | | |
| Liabilities: | | | | | | | | | | | | | | | |
| Derivatives | $ | 143.2 | | | $ | — | | | $ | 143.2 | | | $ | — | | | $ | 44.4 | | | $ | — | | | $ | 44.4 | | | $ | — | |
| Total liabilities | $ | 143.2 | | | $ | — | | | $ | 143.2 | | | $ | — | | | $ | 44.4 | | | $ | — | | | $ | 44.4 | | | $ | — | |
Investments represent securities held in trusts for the non-qualified deferred compensation plan and executive severance plan. Investments are classified as trading securities and are valued based on quoted prices in active markets for identical assets that the Company has the ability to access. As of December 31, 2025, $1.5 million of investments are recorded in other current assets in the Consolidated Balance Sheet related to investments that are expected to be redeemed within the next twelve months. The remaining investments are reported separately in Other assets on the Consolidated Balance Sheets. Investments include an unrealized gain of $0.1 million and $1.1 million as of December 31, 2025 and 2024, respectively.
The Company uses the income approach to measure the fair value of derivative instruments on a recurring basis. This approach calculates the present value of the future cash flow by measuring the change between the derivative contract rate and the published market indicative currency rate, multiplied by the contract notional values, and applying an appropriate discount rate as well as a factor of credit risk.
The carrying amounts of cash and cash equivalents, trade receivables and payables, as well as financial instruments included in other current assets and other current liabilities, approximate fair values because of their short-term maturities.
The carrying values and the estimated fair values of debt financial instruments as of December 31 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| 2025 | | 2024 |
| (In millions) | Carrying Value | | Estimated Fair Value | | Carrying Value | | Estimated Fair Value |
| 2026 Convertible senior notes | $ | 401.7 | | | $ | 406.8 | | | $ | 399.4 | | | $ | 398.2 | |
| 2030 Convertible senior notes | 560.3 | | | 594.5 | | | — | | | — | |
| Senior Secured Term Loan B | 893.2 | | | 893.2 | | | — | | | — | |
| Revolving credit facility, expires January 2, 2030 | 37.6 | | | 37.6 | | | 854.0 | | | 854.0 | |
| Other | 2.0 | | | 2.0 | | | — | | | — | |
The carrying values of the Company’s revolving credit facility recorded in long-term debt on the Balance Sheet approximate their fair values due to their variable interest rates. The fair value of the Convertible senior notes is estimated using Level 2 inputs as they are not registered securities nor listed on any securities exchange but may be traded by qualified institutional buyers.
NOTE 18. COMMITMENTS AND CONTINGENCIES
In the normal course of business, the Company is at times subject to pending and threatened legal actions, some for which the relief or damages sought may be substantial. Although the Company is not able to predict the outcome of such actions, after reviewing all pending and threatened actions with counsel and based on information currently available, management believes that the outcome of such actions, individually or in the aggregate, will not have a material adverse effect on results of operations or financial position. However, it is possible that the ultimate resolution of such matters, if unfavorable, may be material to results of operations in a particular future period as the time and amount of any resolution of such actions and its relationship to the future results of operations are not currently known.
Liabilities are established for pending legal claims only when losses associated with the claims are judged to be probable, and the loss can be reasonably estimated. In many lawsuits and arbitration, it is not considered probable that a liability has been incurred or not possible to estimate the ultimate or minimum amount of that liability until the case is close to resolution, in which case no liability would be recognized until that time.
Guarantees and Product Warranties
In the ordinary course of business with customers, vendors and others, the Company issues standby letters of credit, performance bonds, surety bonds and other guarantees. These financial instruments, which totaled approximately $69.9 million at December 31, 2025, represent guarantees of future performance. The Company also has provided approximately $8.8 million of bank guarantees and letters of credit to secure a portion of its existing financial obligations. The majority of these financial instruments expire within one year; the Company expects to replace them through the issuance of new or the extension of existing letters of credit and surety bonds.
In some instances, the Company guarantees its customers’ financing arrangements. The Company is responsible for payment of any unpaid amounts but will receive indemnification from third parties for ninety percent of the contract values. In addition, the Company generally retains recourse to the equipment sold. As of December 31, 2025, the gross value of such arrangements was $3.2 million, of which the Company’s net exposure under such guarantees was $0.3 million.
The Company provides warranties of various lengths and terms to certain customers based on standard terms and conditions and negotiated agreements. The Company provides for the estimated cost of warranties at the time revenue is recognized for products where reliable, historical experience of warranty claims and costs exists. The Company also provides a warranty liability when additional specific obligations are identified. The warranty obligation reflected in other current liabilities in the Consolidated Balance Sheets is based on historical experience by product and considers failure rates and the related costs in correcting a product failure.
Warranty cost and accrual information were as follows:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Balance at beginning of year | $ | 12.2 | | | $ | 9.9 | |
| Expenses for new warranties | 10.7 | | | 10.2 | |
| Adjustments to existing accruals | — | | | (0.8) | |
| Claims paid | (11.3) | | | (6.7) | |
| Added through acquisition | 8.0 | | | — | |
| Translation | 1.5 | | | (0.4) | |
| Balance at end of year | $ | 21.1 | | | $ | 12.2 | |
NOTE 19. LEASES
Lessee Accounting
The components of the Company’s lease costs for the years ended December 31, were as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Fixed lease cost | $ | 31.7 | | | $ | 16.1 | | | $ | 16.5 | |
| Variable lease cost | 7.7 | | | 3.4 | | | 4.0 | |
| Total operating lease cost | $ | 39.4 | | | $ | 19.5 | | | $ | 20.5 | |
Included within operating lease costs are short-term lease costs, which were $2.8 million, $1.1 million, and $1.4 million for the years ended December 31, 2025, 2024, and 2023, respectively, and sublease income which was immaterial for the years ended December 31, 2025, 2024, and 2023. The Company’s finance lease cost was $4.9 million for the year ended December 31, 2025, and immaterial for the years ended December 31, 2024 and 2023.
Supplemental cash flow information related to the Company’s leases for the years ended December 31, was as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | 2025 | | 2024 | | 2023 |
| Operating cash flows from operating leases | $ | 27.0 | | | $ | 14.5 | | | $ | 15.0 | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 29.6 | | | 9.2 | | | 10.8 | |
Financing cash flows from finance leases were $4.8 million for the year ended December 31, 2025, and immaterial for the years ended December 31, 2024 and 2023. Right-of-use assets obtained in exchange for new finance lease liabilities were $4.6 million, $1.3 million, and $1.2 million for the years ended December 31, 2025, 2024, and 2023.
Supplemental balance sheet information related to the Company’s leases as of December 31, was as follows:
| | | | | | | | | | | | | | | | | |
| (In millions) | Balance Sheet Classification | | 2025 | | 2024 |
| Lease ROU assets: | | | | | |
| Operating | Other assets | | $ | 75.1 | | | $ | 32.3 | |
Finance (a) | Net property, plant and equipment | | 12.6 | | | 4.7 | |
| Total lease ROU assets | | | $ | 87.7 | | | $ | 37.0 | |
| | | | | |
| Lease liabilities: | | | | | |
| Current: | | | | | |
| Operating | Other current liabilities | | $ | 22.0 | | | $ | 11.9 | |
Finance (a) | Other current liabilities | | 4.2 | | | 1.0 | |
| Long-term: | | | | | |
| Operating | Other liabilities | | 56.2 | | | 21.7 | |
Finance (a) | Other liabilities | | 6.0 | | | 1.4 | |
| Total lease liabilities | | | $ | 88.4 | | | $ | 36.0 | |
(a) Finance leases include real estate leases for which the Company is a lessee for an indefinite lease term. However, these finance leases have no lease liability outstanding as of December 31, 2025 as no amounts are due under the lease.
The following table presents the weighted-average remaining lease term and discount rates for the leases for which the Company is the lessee:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Weighted-average remaining lease term (years) | | | |
| Operating leases | 5.3 | | 3.9 |
Finance leases(a) | 3.0 | | 3.0 |
| Weighted-average discount rate | | | |
| Operating leases | 6.1% | | 5.5% |
Finance leases(a) | 6.2% | | 6.1% |
(a) Excludes real estate finance leases for which the Company is a lessee for an indefinite lease term and has no lease liability outstanding as of December 31, 2025.
The majority of ROU assets and lease liabilities, approximately 69%, relate to real estate leases, with the remaining amount primarily comprised of vehicle leases.
Maturity of operating and finance lease liabilities as of December 31, 2025, in millions: | | | | | | | | | | | |
| (In millions) | Operating Leases | | Finance Leases |
Year 1(a) | $ | 22.2 | | | $ | 4.7 | |
| Year 2 | 19.2 | | | 3.2 | |
| Year 3 | 14.8 | | | 2.0 | |
| Year 4 | 10.8 | | | 0.9 | |
| Year 5 | 5.6 | | | 0.2 | |
| After Year 5 | 22.1 | | | 0.1 | |
| Total lease payments | $ | 94.7 | | | $ | 11.1 | |
| Less: Interest on lease payments | (16.5) | | | (0.9) | |
| Present value of lease liabilities | $ | 78.2 | | | $ | 10.2 | |
(a) Represents the next 12 months
Lessor Accounting
Operating Leases:
The following tables provide the required information regarding operating leases for which the Company is the lessor.
Operating Lease Revenue:
| | | | | | | | | | | | | | | | | |
| (In millions) | December 31, 2025 | | December 31, 2024 | | December 31, 2023 |
| Fixed payment revenue | $ | 70.8 | | | $ | 67.2 | | | $ | 63.8 | |
| Variable payment revenue | 30.0 | | | 28.6 | | | 33.8 | |
| Total | $ | 100.8 | | | $ | 95.8 | | | $ | 97.6 | |
Operating Lessor Maturity Analysis as of December 31, 2025, in millions:
| | | | | |
Year 1(a) | $ | 58.7 | |
| Year 2 | 38.8 | |
| Year 3 | 32.7 | |
| Year 4 | 21.5 | |
| Year 5 | 10.7 | |
| After Year 5 | 14.9 | |
| Total lease receivables | $ | 177.3 | |
(a) Represents the next 12 months
Sales-Type Leases:
Sales-Type Lessor Maturity Analysis as of December 31, 2025, in millions:
| | | | | |
Year 1(a) | $ | 1.7 | |
| Year 2 | 1.7 | |
| Year 3 | 1.3 | |
Year 4 | 1.0 | |
Year 5 | 0.4 | |
After Year 5 | — | |
| Total lease receivables | $ | 6.1 | |
(a) Represents the next 12 months
Sales-type lease revenue was $3.3 million, $5.8 million, and $5.2 million for the years ended December 31, 2025, 2024, and 2023 respectively.
Our net investment in sales-type leases were classified in the Consolidated Balance Sheets as of December 31, as follows:
| | | | | | | | | | | |
| (In millions) | 2025 | | 2024 |
| Trade receivables, net of allowances | $ | 3.5 | | | $ | 4.1 | |
| Other assets | 4.9 | | | 4.6 | |
| Total | $ | 8.4 | | | $ | 8.7 | |
NOTE 20. BUSINESS SEGMENTS
During the fourth quarter of 2025, the Company realigned its reportable segments to better reflect the continued integration of its operating model. Giving effect to the realignment, the Company operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Company defines its segments based on which internally reported financial information is regularly reviewed by the Chief Operating Decision Maker (CODM) to analyze financial performance, make decisions and allocate resources. Prior year segment information has been recast in these financial statements to conform to current year presentation.
•The Protein Solutions segment includes businesses that provide solutions for initial stage processing and harvesting of animal proteins, primarily focusing on poultry, pork, fish, and beef.
•The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready to eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical and nutraceutical, and warehouse automation end markets.
The Company's Chief Executive Officer is the CODM, who assesses the segments’ performance using each segment’s Adjusted EBITDA. The CODM is not regularly provided with and does not evaluate the segments by using each segment’s total assets and therefore, each segment’s total assets are not disclosed.
Segment profitability measures and significant expenses
The following tables present financial information for the Company's reportable segments and significant expenses regularly provided to the CODM:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2025 |
| (In millions) | Protein Solutions | | Prepared Food and Beverage Solutions | | Total |
| Revenue | $ | 1,716.2 | | | $ | 2,082.0 | | | |
Less: | | | | | |
| Cost of sales | 1,087.9 | | | 1,375.7 | | | |
| Research and development | 75.6 | | | 36.8 | | | |
Other segment items(1) | 326.3 | | | 432.2 | | | |
Add: | | | | | |
| Depreciation and amortization | 118.3 | | | 121.4 | | | |
| Segment Adjusted EBITDA | $ | 344.7 | | | $ | 358.7 | | | $ | 703.4 | |
Less: | | | | | |
| Interest (income) | | | | | (11.1) | |
| Interest expense | | | | | 114.4 | |
| Other (income) | | | | | (10.6) | |
| Loss on investment | | | | | 10.6 | |
| Pension expense, other than service cost | | | | | 148.5 | |
| Restructuring related costs | | | | | 30.7 | |
| M&A related costs | | | | | 114.5 | |
| Depreciation and amortization | | | | | 266.2 | |
| Unallocated amounts: | | | | | |
Corporate expense(2) | | | | | 103.0 | |
| Income from continuing operations before income taxes | | | | | $ | (62.4) | |
| | | | | |
| Capital expenditures | | | | | $ | 103.6 | |
(1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business.
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2024 |
| (In millions) | Protein Solutions | | Prepared Food and Beverage Solutions | | Total |
| Revenue | $ | 168.7 | | | $ | 1,547.3 | | | |
Less: | | | | | |
| Cost of sales | 92.0 | | | 997.5 | | | |
| Research and development | 3.2 | | | 17.7 | | | |
Other segment items(1) | 29.6 | | | 304.3 | | | |
Add: | | | | | |
| Depreciation and amortization | 13.6 | | | 73.4 | | | |
| Segment Adjusted EBITDA | $ | 57.5 | | | $ | 301.2 | | | $ | 358.7 | |
Less: | | | | | |
| Interest (income) | | | | | (23.7) | |
| Interest expense | | | | | 19.4 | |
| Pension expense, other than service cost | | | | | 27.3 | |
| Restructuring related costs | | | | | 1.4 | |
| M&A related costs | | | | | 85.9 | |
| Depreciation and amortization | | | | | 89.4 | |
| Unallocated amounts: | | | | | |
Corporate expense(2) | | | | | 63.6 | |
| Income from continuing operations before income taxes | | | | | $ | 95.4 | |
| | | | | |
| Capital expenditures | | | | | $ | 37.9 | |
(1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business.
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2023 |
| (In millions) | Protein Solutions | | Prepared Food and Beverage Solutions | | Total |
| Revenue | $ | 187.8 | | | $ | 1,476.6 | | | |
Less: | | | | | |
| Cost of sales | 108.5 | | | 970.2 | | | |
| Research and development | 4.9 | | | 15.7 | | | |
Other segment items(1) | 30.6 | | | 287.2 | | | |
Add: | | | | | |
| Depreciation and amortization | 13.9 | | | 74.0 | | | |
| Segment Adjusted EBITDA | $ | 57.7 | | | $ | 277.5 | | | $ | 335.2 | |
Less: | | | | | |
| Interest (income) | | | | | (13.4) | |
| Interest expense | | | | | 24.3 | |
| | | | | |
| Pension expense, other than service cost | | | | | 0.7 | |
| Restructuring related costs | | | | | 11.4 | |
| M&A related costs | | | | | 6.0 | |
| Depreciation and amortization | | | | | 91.3 | |
| Unallocated amounts: | | | | | |
Corporate expense(2) | | | | | 61.8 | |
| Income from continuing operations before income taxes | | | | | $ | 153.1 | |
| | | | | |
| Capital expenditures | | | | | $ | 55.1 | |
(1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business.
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above.
Geographic segment information
Geographic segment sales were identified based on the location where the Company’s products and services were delivered.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (In millions) | 2025 | | 2024 | | 2023 |
| Revenue (by location of customers): | | | | | |
| United States | $ | 1,438.9 | | | $ | 932.3 | | | $ | 949.3 | |
| All other countries | 2,359.3 | | | 783.7 | | | 715.1 | |
| Total revenue | $ | 3,798.2 | | | $ | 1,716.0 | | | $ | 1,664.4 | |
Geographic segment long-lived assets include property, plant and equipment, net and certain other non-current assets.
| | | | | | | | | | | |
| Year Ended December 31, |
| (In millions) | 2025 | | 2024 |
| Long-lived assets: | | | |
| United States | $ | 316.9 | | | $ | 232.7 | |
| Netherlands | 206.8 | | | 4.3 | |
| All other countries | 398.3 | | | 100.3 | |
| Total long-lived assets | $ | 922.0 | | | $ | 337.3 | |
NOTE 21. RESTRUCTURING
Restructuring charges primarily consist of employee separation benefits under existing severance programs, foreign statutory termination benefits, certain one-time termination benefits, contract termination costs, asset impairment charges and other costs that are associated with restructuring actions. Certain restructuring charges are accrued prior to payments made in accordance with applicable guidance. For such charges, the amounts are determined based on estimates prepared at the time the restructuring actions were approved by management. Inventory write offs due to restructuring are reported in Cost of products and all other restructuring charges are reported as Restructuring expenses in the Statements of Income.
In the third quarter of 2022, the Company implemented a restructuring plan (the “2022/2023 restructuring plan”) to optimize the overall cost structure for the Company on a global basis. The Company completed the 2022/2023 restructuring plan as of March 31, 2024. The total cost in connection with this plan was $17.5 million.
The Company released $0.5 million of the liability related to the 2022/2023 restructuring plan during the year ended December 31, 2025, which it no longer expects to pay due to actual severance payments differing from the original estimates and natural attrition of employees. Restructuring charges related to the 2022/2023 restructuring plan of $1.4 million and $11.4 million were recognized in Restructuring expense within the Consolidated Statements of Income for the years ended December 31, 2024 and 2023, respectively.
In the first quarter of 2025, the Company implemented a restructuring plan (the “JBT Marel 2025 Integration restructuring plan”) aiming to achieve a portion of its synergy targets as a result of the Marel acquisition to optimize the overall cost structure for the combined Company on a global basis. The initiatives under this plan include streamlining operations and adjusting our general and administrative infrastructure to meet the strategic needs of the Company. The total estimated cost in connection with this plan was revised in the third quarter from $25.0 million to $30.0 million to a range of $30.0 million to $35.0 million, and was further updated at year-end to a range of $55.0 million to $60.0 million. These changes are due to additional footprint optimization initiatives. The Company recognized restructuring charges of $31.2 million, net of a cumulative release of the related liability of $0.4 million through December 31, 2025, and expects to recognize the remaining costs by the end of 2026.
The following table details the cumulative restructuring charges reported in operating income for the JBT Marel 2025 Integration restructuring plan since its implementation:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Cumulative Amount | | As of the Quarter Ended | | Cumulative Amount |
| (In millions) | Balance as of December 31, 2024 | | March 31, 2025 | | June 30, 2025 | | September 30, 2025 | | December 31, 2025 | | Balance as of December 31, 2025 |
| Severance and related expense | — | | | 11.1 | | | 4.5 | | | 6.4 | | | 7.3 | | | 29.3 | |
| Inventory write-off | — | | | — | | | 0.3 | | | — | | | — | | | 0.3 | |
| Other | — | | | — | | | 0.8 | | | 1.0 | | | (0.2) | | | 1.6 | |
| Total restructuring charges, net | $ | — | | | $ | 11.1 | | | $ | 5.6 | | | $ | 7.4 | | | $ | 7.1 | | | $ | 31.2 | |
Restructuring charges related to the JBT Marel 2025 Integration restructuring plan are reported within the following financial statement line items within the Consolidated Statements of Income for the year ended December 31, 2025.
| | | | | |
| (In millions) | 2025 |
Cost of sales (1) | 0.2 | |
Selling, general and administrative expense (2) | 1.2 | |
Restructuring expense (3) | 29.8 | |
| Total restructuring related costs | 31.2 | |
(1) Restructuring charges reported in Cost of sales are related to inventory write-offs.
(2) Restructuring charges reported in Selling, general and administrative expense are related to property, plant, and equipment impairment charges.
(3) Restructuring charges reported in Restructuring expense primarily include severance and related charges.
Liability balances related to the JBT Marel 2025 Integration restructuring plan are included in Accounts payable, trade and other and Other current liabilities in the accompanying Consolidated Balance Sheets. The table below details the restructuring activities for the year ended December 31, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Impact to Earnings | | | | |
| (In millions) | Balance as of December 31, 2024 | | Charged to Earnings | | Releases | | Cash Payments | | Balance as of December 31, 2025 |
| Severance and related expense | $ | — | | | $ | 29.6 | | | $ | (0.4) | | | $ | (13.7) | | | $ | 15.5 | |
| Other | — | | | 0.6 | | | — | | | (0.6) | | | — | |
| Total | $ | — | | | $ | 30.2 | | | $ | (0.4) | | | $ | (14.3) | | | $ | 15.5 | |
Schedule II—Valuation and Qualifying Accounts